Biochem.
J.
(1991) 274,
1-14
(Printed
in
Great
Britain)
REVIEW
ARTICLE
The
dynamics
of
actin
and
myosin
association
and
the
crossbridge
model
of
muscle
contraction
Michael
A.
GEEVES
Department
of
Biochemistry,
School
of
Medical
Sciences,
University
of
Bristol,
Bristol
BS8
1TD,
U.K.
INTRODUCTION
The
production
of
mechanical
force
in
muscle
is
believed
to
be
the
result
of
a
dynamic
interaction
between
the
proteins
in
two
sets
of
interdigitating
filaments,
the
thick
myosin
and
thin
actin
filaments
(Fig.
1).
In
the
cycling
crossbridge
model
of
muscle
contraction,
myosin
heads
project
from
the
surface
of
the
thick
filament
and
form
crossbridges
with
actin
of
the
thin
filament.
Hydrolysis
of
ATP
by
myosin
then
drives
a
cycle
of
interaction
between
the
actin
and
myosin
which
tends
to
move
the
two
filaments
past
each
other
[1,2].
Early
studies
of
the
properties
of
the
isolated
actin
and
myosin
concentrated
on
the
mechanism
of
ATP
hydrolysis
by
myosin
(and
its
proteolytic
subfragments
SI
and
HMM,
Fig.
1)
and
the
activation
of
the
ATPase
by
actin.
The
essential
features
of
this
mechanism
were
well
established
by
the
mid-1970s
and
have
been
reviewed
extensively
[3-5].
The
details
of
the
mechanism
have
been
revised
[6-10]
but
the
principal
events
remain
unchanged.
More
recent
work
has
concentrated
on
attempts
to
correlate
the
events
of
the
ATP
hydrolysis
mechanism
with
the
mechanism
of
force
generation.
The
cycling
crossbridge
model
is
a
mechanical
model,
the
crossbridge
is
a
physical
link
between
the
two
filaments
and
force
is
generated
by
a
change
in
the
structure
of
the
crossbridge,
usually
conceptualized
as
a
change
in
the
angle
at
which
the
myosin
head
binds
to
the
thin
filament.
The
true
nature
of
this
change
in
structure
remains
elusive
and
its
definition
remains
the
principle
aim
of
work
in
the
field.
The
definition
of
this
structural
change
will
require
contributions
from
many
different
sources
and
ultimately
will
provide
the
high-resolution
structures
of
the
individual
molecular
components,
their
organization
in
the
muscle
and
the
way
in
which
the
structures
change
on
a
millisecond
time
scale.
These
aims
are
still
some
way
from
being
realized.
This
review
will
consider
the
information
available
from
studies
of
the
dynamics
of
the
interaction
between
actin
and
myosin
in
solution
and
how
these
studies
can
help
to
focus
on
where
to
look
for
these
structural
changes.
HISTORICAL
BACKGROUND
The
first
major
advance
in
correlating
the
events
of
the
enzymic
breakdown
of
ATP
with
the
proposed
crossbridge
cycle
came
from
the
transient-kinetic
studies
of
Lymn
&
Taylor
[11]
using
purified
actin
and
myosin.
They
were
able
to
explain
two
earlier
apparently
paradoxical
observations.
In
the
absence
of
ATP,
actin
binds
to
myosin
very
tightly
(Kr
-8
107
M-1)
and
the
presence
of
ATP
reduces
the
association
constant
to
<
104
M-1.
However
the
ATPase
rate
of
myosin
is
low
(0.1
s-1)
and
actin
accelerates
this
even
though
the
two
proteins
are
largely
dissociated.
The
extent
of
acceleration
is
dependent
upon
actin
concentration
and
ionic
strength
but
can
be
as
much
as
200-fold.
Lymn
&
Taylor
were
able
to
show
that
these
steady
state
observations
were
compatible
with
a
transient
interaction
be-
tween
actin
and
myosin.
Their
principal
observations
were
as
follows.
In
the
absence
of
actin,
ATP
binds
rapidly
to
myosin
(second
order
rate
constant
2
x
10
M-1
s-1)
and
is
hydrolysed
to
ADP
and
phosphate
at
>
100
s-I
but
slow
release
of
the
products
limits
the
turnover
to
0.1
s-
.
On
addition
of
ATP
to
actomyosin
the
two
proteins
rapidly
dissociate,
and
then
ATP
is
hydrolysed
on
myosin
at
the
same
rate
as
in
the
absence
of
actin.
Lymn
&
Taylor
proposed
that
actin
rebinds
to
the
myosin
products
complex
at
this
point
and
promotes
the
release
of
products
from
myosin.
Rebinding
of
ATP
to
actomyosin
then
dissociates
the
two
proteins
once
more.
The
model
therefore
requires
a
cycle
of
attachment
and
detachment
between
actin
and
myosin
for
each
ATP
hydrolysed
and
this
is
precisely
the
type
of
mechanism
which
is
required
by
the
cycling
crossbridge
model
of
contraction
proposed
earlier.
The
original
model
of
Lymn
&
Taylor
is
shown
in
Fig.
2,
and
the
biochemical
model
is
redrawn
in
more
detail in
Fig.
3(a).
In
drawing
the
biochemical
model
and
the
crossbridge
cycle
side
by
side
as
Lymn
&
Taylor
were
able
to
do,
two
additional
features
of
the
model
became
apparent;
the
force-generating
event
is
associated
with
the
loss
of
the
products
of
the
ATPase
reaction
from
the
myosin
active
site
and
therefore
the
actomyosin
complex
represents
a
ground
state
at
the
end
of
the
ATPase
cycle.
Secondly,
if
the
force-generating
event
is
a
structural
change
such
as
a
change
in
the
angle
of
attachment
of
myosin
to
actin
(as
proposed
in
the
models
of
A.
F.
Huxley
&
H.
E.
Huxley
[1,2])
then
a
recovery
stroke
is
required
during
the
detached
part
of
the
cycle
(which
in
the
Lymn
&
Taylor
model
was
located
as
part
of
the
hydrolysis
step).
It
is
important
to
emphasize
that
these
two
features
of
the
model
did
not
come
from
any
experimental
data
but
were
implicit
in
the
model
devised
to
accommodate
the
experimental
findings.
The
next
major
development
in
correlating
events
of
the
actomyosin
ATPase
reaction
with
a
crossbridge
model
came
from
the
work
of
Eisenberg
and
his
collaborators.
Stein
et
al.
[12]
showed
that
although
ATP
reduced
the
affinity
of
Sl
for
actin
more
than
1000-fold,
detachment
followed
by
hydrolysis
and
reattachment
was
not
an
obligatory
pathway.
Hydrolysis
of
ATP
by
acto
SI
without
dissociation
was
possible
at
high
protein
concentration.
The
work
of
Greene
&
Eisenberg
[13]
on
the
equilibrium
interaction
between
actin
and
myosin
subfragment
1
established
that
myosin
and
myosin
nucleotide
complexes
formed
two
classes
of
complexes
with
actin;
those
which
bound
actin
strongly
(M,
M
ADP,
K,,,
>
105
M-1)
and
those
which
bound
actin
weakly
(M-ATP,
and
M
ADP-P,
K,,s
<
105
M-1).
In
the
weak
complexes,
actin
was
in
rapid
equi-
Vol.
274
Abbreviations
used:
SI,
myosin
subfragment
1;
HMM,
heavy
meromyosin;
ATPyS,
adenosine
5'-[y-thio]triphosphate;
AMP-PNP,
adenosine
5'-[fiy-imido]triphosphate;
FRET,
fluorescence
energy
transfer;
mant,
N-methylanthraniloyl;
Tm,
tropomyosin;
Tn,
troponin;
in
equations
A,
N,
and
M
refer
to
actin,
nucleotide
and
myosin
(or
its
subfragments)
respectively.
I
M.
A.
Geeves
Thick
filament
(a)
(b)
S~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
I%"
|
Lig
h
It
chaiins
D>ISS
I
i
.
I
LMM
HMM
Fig.
1.
The
principal
proteins
of
muscle
(a)
Diagram
of
overlapping
thick
and
thin
filaments
at
the
centre
of
a
sarcomere
of
relaxed
muscle.
For
clarity,
the
lateral
separation
of
the
filaments
has
been
drawn
greater
than
in
vivo,
and
the
M-line
structure
omitted.
The
thin
filament
is
a
1
,sm
long
polymer
of
actin,
which
is
a
single-
polypeptide,
globular
protein
of
Mr
42000.
The
crystal
structure
of
monomeric
actin
in
a
complex
with
DNAase
I
has
recently
been
solved
to
<
0.3
nm
resolution
[109a]
and
the
orientation
of
the
monomer
in
the
filament
has
been
proposed
[109b].
Associated
with
the
thin
filament
are
the
control
proteins
troponin
and
tropomyosin
which
interact
with
calcium
to
regulate
the
interaction
of
actin
with
myosin.
The
thick
filament
is
a
bipolar
polymer
of
myosin.
Myosin
is
an
Mr
520000
protein
and
consists
of
six
polypeptide
chains,
two
identical
heavy
chains
and
four
light
chains
(from
[56]
with
permission).
(b)
Myosin
is
insoluble
at
physiological
ionic
strength
and
therefore
biochemical
studies
use
proteolytic
fragments
of
myosin.
Heavy
meromyosin
(HMM)
has
a
short
tail
and
two
globular
heads
with
all
of
the
light
chains
intact
(Mr
340000).
Subfragment
1
(S1)
is
the
globular
head
group
with
one
or
two
light
chains
per
head
(Mr
115000).
Both
HMM
and
Sl
retain
the
ATPase
activity
and
the
actin-binding
properties
of
the
parent
myosin.
The
thick
filament
is
assembled
by
the
tails
of
the
myosin
packing
together
parallel
to
the
filament
axis
with
the
tails
pointing
towards
the centre
of
the
filament.
librium
between
bound
and
free
states.
In
the
strong
complexes,
free
actin
was
only
in
slow
exchange
with
bound
actin.
The
effect
of
this
on
the
Lymn
&
Taylor
model
was
to
add
the
vertical
equilibrium
arrows
in
Fig.
3
[14,15].
This
model
implies
that
force
generation
is
associated
with
the
transition
from
the
weakly
bound
actin
to
the
strongly
bound
actin
which
occurs
during
this
product
dissociation
step,
as
in
the
Lymn
&
Taylor
model.
Eisenberg
&
Greene
called
the
weak
state
a
900
crossbridge
and
the
strong
state
a
450
crossbridge
to
emphasize
the
corres-
pondence
between
the
solution
model
and
the
rotating
cross-
bridge
model.
This
assignment
makes
a
fundamental
difference
to
the
recovery
stroke
of
the
crossbridge
which
in
the
Lymn
&
Taylor
model
occurs
during
detachment.
In
the
Eisenberg
&
Greene
model
the
crossbridge
must
return
to
a
weak
binding
(900)
state
before
it
can
detach,
i.e.
the
force-generating
event
is
reversed
before
the
crossbridge
detaches.
This
can
clearly
present
problems
for
the
efficient
production
of
mechanical
energy
by
the
cycle,
as
was
pointed
out
by
the
authors
when
the
model
was
first
proposed.
Their
suggestion
for
avoiding
this
was
that
the
reversal
of
the
power
stroke
did
occur
but
that
it
was
a
rapid
process
and
the
following
detachment
was
also
a
very
fast
step.
Thus
the
lifetime
of
this
'negatively
strained
crossbridge'
was
very
short
and
therefore
contributed
little
to
the
overall
force
produced
in
the
cycle.
Goody
&
Holmes
[16]
reviewed
the
interaction
between
myosin,
actin
and
nucleotide,
and
emphasized
the
competitive
nature
of
the
binding
of
actin
and
nucleotide
to
myosin.
They
pointed
out
that
the
tighter
a
nucleotide
or
nucleotide
analogue
bound
to
myosin,
the
weaker
the
interaction
between
actin
and
the
myosin
-
nucleotide
complex.
Further,
they
suggested
that
myosin
nucleotide
complexes
could
be
classified
as
a
continuum
between
those
possessing
weak
and
strong
actin-binding
proper-
ties
and
this
could be
accounted
for
by
a
two-step
association
reaction
between
actin
and
myosin-
nucleotide
complexes.
In
this
model,
actin
binds
initially
to
form
the
'attached
state'
(A
in
eqn.
1)
in
which
the
actin
is
relatively
weakly
bound
and
is
in
rapid
equilibrium
with
free
actin.
This
complex
can
then
be
isomerized
to
the
'rigor-like'
complex
(R)
in
which
actin
is
tightly
bound
and
the
nucleotide
is
correspondingly
more
weakly
bound
(at
low
concentrations
of
nucleotide
the
nucleotide
can
subsequently
dissociate).
KI
K11
KN
A+M
N=A-M*N=A
M*N=AM+N
(1)
A
state
R
state
At
the
time
this
idea
was
proposed
there
was
some
kinetic
evidence
for
more
than
one
acto
S1
complex
in
the
presence
of
ADP
[17,18],
in
the
presence
of
ATP
[19]
and
in
the
presence
of
adenosine
5'-[/Jy-imido]triphosphate
('AMP-PNP')
[20].
Geeves
1991
2
Dynamics
of
muscle
contraction
(a)
(4)
(3)
E
(b)
A-M-D-P
(3)
±A
M-D-P
(1)
(2)
(4)
Do
A-M
-D,P
+ATI
(1)
M*T
-(2
(2)
Fig.
2.
The
Lyme-Taylor
1111
model
of
the
actomyosin
ATPase
and
the
crossbridge
cycle
(a)
Contractile
cycle
for
a
single
crossbridge.
Actin
sites
which
are
suitably
orientated
to
interact
with
a
crossbridge
are
indicated
by
circles.
(b)
Steps
in
the
chemical
mechanism
for
ATP
hydrolysis
by
actomyosin.
Binding
of
ATP
and
dissociation
of
actin
is
shown
as
a
single
step
because
actin
dissociation
is
very
fast
following
substrate
binding.
Goody
&
Gutfreund
[21]
drew
this
evidence
together
and
proposed
a
detailed
biochemical
model
of
the
actomyosin
ATPase.
The
model,
referred
to
as
the
'3G'
model,
is
shown
in
Fig. 3
drawn
at
right
angles
to
the
way
it
was
drawn
in
the
original
form
in
order
to
emphasize
the
correspondence
with
the
previous
models.
In
this
model,
myosin-nucleotide
complexes
bind
actin
in
a
two-step
reaction
and
the
isomerization
from
the
attached
A-M
-N
to
the
A
M
-N
state
represents
the
trans-
formation
from
a
weakly
to
a
strongly
attached
state
as
defined
by
Eisenberg
&
Greene.
Whether
a
particular
myosin
-
nucleotide
complex
is
classified
as
weak
or
strong
actin-binding
state
simply
depends
upon
the
value
of
the
equilibrium
constant
KII.
If
KII
>
1
then
the
A
*
M
*
N
state
predominates
and
the
myosin
-
nucleotide
is
strong
actin-binding;
if
KII
<
1
then
the
A-M
-
N
state
predominates
and
it
is
a
weak
actin-binding
complex.
It
was
suggested
that
the
value
of
K,
was
103-104
M-1,
independent
of
the
occupancy
of
the
myosin
nucleotide-binding
site.
As
the
ATPase
reaction
progresses
the
predominant
state
of
the
acto
-
S
1
nucleotide
complex
alternates
between
the
strongly
and
weakly
attached
states.
In
the
absence
of
nucleotide
the
rigor
state
predominates
(KII
=
200)
and
on
binding
ATP,
K,I
is
reduced
to
<
0.01
and
the
weakly
attached
state
predominates
as
in
the
Eisenberg
&
Greene
model.
As
ATP
is
hydrolysed
and
the
products
are
sequentially
released,
the
actomyosin
progress-
ively
reverts
to
the
strongly
attached
rigor-like
state
and
in
doing
so
can
generate
mechanical
force
between
the
two
proteins.
Geeves
et
al.
[21]
went
on
to
discuss
how
the
transition
from
the
attached
to
the
rigor-like
state
could
be
coupled
to
force
generation.
M
-
M-T
i
M-D.P
MD
M
A-M,-
i
A-M-T
A-M.D.P
iA.MD-i
A-M
%v
_
J
f
Weak
binding
Strong
binding
states
states
M
M-T
M-D-P
M-D
M
Detached
'states
'
'
i i
t
1
Attached
(A)
A-M
A-M.T
,
A-M.D.P
A-MD
A-M
states
|
1
1
1
1
1
Rigor-like
(R)
AM
iA-M-T
iAM-D-P
A-MD
A-M
states
Lymn
&
Taylor
(1971
)
Eisenberg
&
Greene
(1980)
Geeves
et
al.
(1984)
Fig.
3.
Biochemical
models
of
the
actomyosin
ATPase
mechanism
(a)
A
redrawing
of
the
Lymn-Taylor
[11]
model.
In
the
original
model
the
order
of
product
release
was
not
specified;
the
AMD
and
MD
states
are
added
here
for
completeness
and
to
emphasize
the
correspondence
with
the
two
other
models.
(b)
The
model
of
Eisenberg
&
Greene
[14].
This
model
allows
for
all
myosin
nucleotide
states
to
interact
with
actin
and
classifies
these
as
weak
(K.
<
l0
M-1)
or
strong
(K.
>
105
M-1)
actin-
binding
states.
In
addition
it
allows
for
the
possibility
of
hydrolysis
of
ATP
by
myosin
whilst
the
actin
remains
attached.
(c)
The
model
of
Geeves,
Goody
&
Gutfreund
[21].
This
is
similar
to
(b),
but
each
myosin
nucleotide
complex
binds
to
actin
in
two
steps.
The weak
or
strong
definition
of
(b)
depends
upon
whether
the
A
or
the
R
state
predominates
for
a
given
nucleotide.
Vol.
274
(b)
(c)
3
M.
A.
Geeves
The
difference
between
this
model
and
the
one
proposed
by
Eisenberg
&
Greene
is
relatively
small,
but
the
implications
for
the
nature
of
the
actin-myosin
interaction
are
more
far-reaching.
This
model
suggests
that
the
conformational
change
which
results
in
force
generation
is
not
a
unique
feature
of
a
particular
actomyosin
nucleotide
complex
but
is
common
to
all
such
complexes.
It
suggests
that
the
actomyosin
rigor
complex
is
a
ground
state
and
ATP
is
required
to
dissociate
actin
from
this
complex.
Hydrolysis
of
ATP
then
allows
the
return
to
the
rigor-
like
state.
The
route
taken
through
the
different
complexes
available
to
any
given
crossbridge
will
depend
on
the
con-
centration
of
available
actin
sites,
the
relative
rates
of
specific
steps
and
the
mechanical
strain
experienced
by
the
crossbridge.
In
1984,
when
the
3G
model
was
proposed,
no
directed
observation
of
the
two
step
binding
reaction
had
been
made.
Before
discussing
the
model
further
it
is
therefore
appropriate
to
consider
the
more
recent
biochemical
evidence
on
actin-myosin
interaction.
EVIDENCE
OF
TWO-STEP
BINDING
OF
ACTIN
TO
S1
IN
SOLUTION
Direct
evidence
of
two
acto
-Sl
complexes
from
pressure
jump
The
most
convenient
monitor
of
actin-myosin
interactions
has
been
the
use
of
light
scattering,
which
is
approximately
linearly
related
to
the
concentration
of
actomyosin
complex
formed
[22,23].
Its
use
in
equilibrium
measurements.
has
been
limited
because
its
sensitivity
is
restricted
to
protein
concentrations
>
5
/tM.
However,
this
signal
has
found
wide
use
in
stopped-flow
kinetic
studies
and
has
been used
to
define
the
rate
of
association
between
actin
and
myosin
and
myosin;nucleotide
complexes
[20,22-26].
Most
of
these
studies
were
consistent
with
a
single-
step
binding
reaction
A+
M
A-
M,
although
many
authors
reported
evidence
of
a
more
complex
reaction;
in
particular
the
rate
of
association
of
actin
with
myosin
(or
myosin
*
nucleotide)
was
slower
than
expected
for
a
diffusion-controlled
reaction.
Equilibrium
perturbation
studies
provide
an
alternative
means
of
studying
association/dissociation
reactions
and
Geeves
&
Gutfreund
[18]
demonstrated
that
increases
in
hydrostatic
pressure
weakened
the
interaction
between
actin
and
myosin
subfragment
1.
They
were
therefore
able
to
use
rapid
pressure
perturbations
to
measure
the
rate
of
the
association
of
both
SI
and
SI
-
ADP
with
actin.
The
measured
rates
were
compatible
with
the
earlier
stopped-flow
studies
but
analysis
of
the
con-
centration
dependence
of
the
pressure-induced
amplitudes
was
not
compatible
with
a
single
step
binding
reaction.
Fluorescent
reporter
groups
covalently
attached
to
proteins
can
provide
a
sensitive
monitor
of
protein-ligand
interactions
and
the
presence
of
a
reactive
thiol
(Cys-374)
on
actin
has
made
such
modifications
routine
[24,27-31].
The
fluorescence
of
a
pyrene
group
covalently
attached
to
Cys-374
is
quenched
by
70
%
when
actin
binds
to
myosin
or
its
subfragments
(S1,
HMM
[27,31]).
The
use
of
this
label
has
greatly
increased
the
ease
and
accuracy
with
which
the
affinity
of
actin
for
myosin
and
myosin-nucleotide
complexes
can
be
measured
by
fluorescence
titration.
Criddle
et
al.
[31]
used
this
label
to
measure
the
rate
and
equilibrium
of
actin
binding
to
SI
and
showed
that
the
presence
of
the
label
had
no
measurable
effect
on
the
actin-SI
interaction.
Using
this
label,
Coates
et
al.
[32]
were
able
to
observe
two
pressure-induced
relaxations
in
solutions
of
acto
SI
in
the
absence
of
any
nucleotide
(Fig.
4).
The
fast
relaxation
was
always
complete
in
the
pressure
release
time
(200
/,s)
and
its
amplitude
increased
as
the
protein
concentration
increased
(i.e.
as
the
fraction
of
the
actin
bound
to
SI
increased).
The
rate
of
the
second
relaxation
was
linearly
dependent
on
protein
concen-
tration
and
its
amplitude
decreased
at
high
protein
concentrations.
This
relaxation
could
also
be
observed
by
light
scattering.
No
pressure-induced
relaxation
was
observed
with
actin
alone;
therefore
the
two
relaxations
must
represent
two
relaxations
of
the
acto
*
SI
complex.
These
experimental
findings
were
interpreted
in
terms
of
the
following
model
in
which
step
2
is
a
pressure-sensitive
transition
(i.e.
increases
in
pressure
results
in
a
reduction
in
K2)
and
pyrene
fluorescence
monitors
step
2
only.
1
2
A
+
M
=
A-M
A-M
(2)
Thus
an
increase
in
pressure
will
reduce
K2
and
lead
to
a
decrease
of
the
overall
affinity
of
actin
for
S1.
At
low
protein
concentrations
therefore,
an
increase
in
pressure
will
result
in
dissociation
of
a
fraction
of
the
acto
SI
complex.
On
pressure
release
a
rapid
re-equilibration
of
A-M
and
A
*
M
will
be
observed
by
fluorescence
followed
by
the
reassociation
of
free
actin
which
can
be
observed
by
both
light
scattering
and
fluorescence.
However,
at
infinitely
high
protein
concentration
increases
in
pressure
will
cause
no
dissociation
of
the
two
proteins
but
will
still
perturb
the
first-order
isomerization
step.
An
important
feature
of
the
model
is
that
the
two
complexes
shown
are
distinct
and
stable.
Consideration
of
the
temperature
dependence
of
k+1
led
Coates
et
al.
[32]
to
suggest
that
this
is
not
a
diffusion-controlled
step
and
therefore
A-M
is
not
a
collision
complex.
A
preceding
step
therefore
probably
exists
which
involves
formation
of
the
collision
complex
and
this
then
becomes
the
A-M
state
with
the
formation
of
specific
protein-protein
interaction
sites.
As
this
collision
complex
is
not
observed
directly
and
is
expected
to
be
a
minor
component
in
any
equilibrium
or
kinetic
experiments,
the
formation
of
the
A-M
state
will
be
treated
as
a
single
event
(i.e.
K1
=
KO
K'1
where
Ko
and
K,
are
the
equilibrium
constants
of
the
collision
complex
formation
and
the
isomerization
to
A-M
steps
respectively).
Thus
the
simplest
model
required
to
fit
the
pressure
jump
data
identifies
two
principle
steps
in
the
association
of
SI
and
actin,
and
K1
and
K2
of
eqn.
2
are
equivalent
to
KI
and
KII
in
eqn.
(1).
A
prediction
of
this
model
is
-that
the
formation
of
any
acto
-SI
-
nucleotide
complex
which
only
occupies
the
weakly
attached
state
(A-M
or
A-M
*
N)
would
not
quench
the
fluorescence
of
the
pyrene
label.
This
prediction
of
the
model
allows
the
generality
of
the
two-step
binding
model
to
be
tested
and
such
experiments
are
discussed
below.
Measurements
of
K,,
in
the
presence
of
nucleotides
The
3G
model
predicts
that
for
acto
-SI
in
the
presence
of
ATP,
the
only
significantly
occupied
state
with
actin
bound
is
the
A-M
-
T
(high
pyrene
fluorescence)
state.
In
principle
this
can
be
tested
by
following
the
change
in
pyrene
fluorescence
when
nucleotide
is
added
to
acto
-SI
under
conditions
where
no
dissociation
of
the
two
proteins
occurs,
i.e.
at
high
protein
concentration.
In
practice
the
experiment
is
more
complex
because
a
sufficiently
high
protein
concentration
cannot
be
achieved
experimentally.
Using
very
low
ionic
strength
to
increase
the
affinity
of
actin
for
S1,
Geeves
et
al.
[33]
showed
that
addition
of
ATP
to
acto
*SI
produces
30%
dissociation
of
acto
-SI
as
judged
by
the
changes
in
light
scattering
(Fig.
5).
The
dissociation
is
only
transient
because
under
these
conditions
the
steady-state
ATP
hydrolysis
is
rapid
and
the
proteins
reassociate
as
the
ATP
concentration
falls.
Monitoring
of
the
pyrene
fluorescence
signal
showed
that
the
signal
change
was
the
same
as
that
expected
for
complete
dissociation
of
the
two
proteins.
This
indicated
that
in
the
presence
of
ATP
<
1
%
of
the
bound
actin
was
in
the
low
fluorescence
rigor-like
state,
establishing
a
value
of
<
0.01
for
KII
as
predicted
in
the
3G
model.
The
assignment
of
the
fluorescence
change
to
the
isomerization
step
alone
then
allows
a
simple
experiment
to
determine
the
1991
4
Dynamics
of
muscle
contraction
41
c
a
4,
4,
0
X(]
r
60-
U,
C-
40
-
20
p
Time
1.;
1.0
0.8.
N
E
2L
E4
0.6
F
0.4[
0.2
0
0
5
10
[pA]
+
[S1
]
(AM)
15
20
5
10
15
20
[pA]
+
[S1]
(AM)
Fig.
4.
Pressure-induced
changes
in
the
fluorescence
of
a
solution
of
pyrene-labelled
actin
and
S1
(a)
A
solution
of
acto
-
SI
was
exposed
to
100
atm
pressure
and
allowed
to
equilibrate.
At
the
small
arrow
the
pressure
was
returned
to
1
atm
within
200
,us.
A
best
fit
single
exponential
(4.1,
13.6
and
50.5
s-1
respectively)
is
superimposed
on
the
slow
relaxation.
The
solutions
were
(i)
2.7
/M-pyr-
actin,
2.4
/Mm-S1,
(ii)
2.6
/tM-pyr-actin,
4.8
,uM-Sl,
(iii)
5.0
/IM-pyr-actin,
15.9
,pM-SI
in
a
pH
7
buffer,
ionic
strength
0.13
M,
20
'C.
In
the
model
of
eqn.2
in
the
text
the
fast
relaxation
is
defined
by:
I/T,
=
k+22
k-2
and
the
slower
relaxation
by:
1/72
=
k+j-([A]+[M])+k-1/(l
+K2)
where
the
bar
indicates
equilibrium
concentrations
and
the
ratio
of
the
two
amplitudes
is
defined
in
terms
of
the
equilibrium
constants:
amp1
1
(l+K2)
amp2
=
+
K1([AJ
+
[M])
K
amp2
42
K2
Plots
of
1
/T2
and
the
ratio
of
the
two
amplitudes
against
protein
concentration
are
shown
in
(b)
and
(c)
respectively.
fraction
of
bound
actin
in
the
two
states
for
any
given
nucleotide.
In
such
an
experiment
addition
of
nucleotide
to
acto
-SI
under
conditions
where
no
dissociation
occurs
produces
a
fluorescence
change
which
can
then
be
directly
related
to
the
fraction
of
the
bound
actin
in
the
two
states
A-M
N
and
A
M
N.
Such
an
approach
was
exploited
by
Geeves
&
Jeffries
[34]
and
a
summary
of
their
results
is
included
in
Table
1.
The
experiment
was
simple
to
perform
in
the
case
of
ADP
as
no
significant
dissociation
of
the
proteins
occurred.
For
the
other
nucleotide
analogues
a
more
complex
approach
was
necessary
in
order
to
correct
for
the
fraction
of
the
actin
which
dissociated
from
Sl.
The
results
of
Geeves
&
Jeffries
[34]
support
the
principal
Vol.
274
(b)
0
0
0
0
(c)
0
0
0
0
0
/
U
w
I
I
z
I
v
_
5
1)
M.
A.
Geeves
2)
C.)
C
0)
U)
0)
0
Fig.
5.
Light
scattering
and
fluorescence
changes
in
pyrene-acto.
Si
on
addition
of
a
small
excess
of
ATP
Curves
labelled
A:
addition
of
10
M-ATP
to
5
/LM-pyrene-actin
and
a
small
excess
(6
IM)
of
SI
(reaction
chamber
concentration).
The
light
scattering
showed
a
rapid
decrease
consistent
with
>
90
%
dissociation
of
actin
from
S1.
This
was
followed
by
reassociation,
as
the
ATP
was
hydrolysed,
back
to
the
original
level.
The
broken
line
represents
the
signal
expected
for
complete
dissociation
of
acto
S1.
The
fluorescence
signal
shows
the
same
features.
Note
that
the
light
scattering
signal
has
been
inverted
to
emphasize
the
similarities
in
the
form
of
the
two
signals.
Curves
labelled
B:
addition
of
75
/M-
ATP
to
5
/SM-actin
and
50
/LM-Sl
.
The
light
scattering
now
shows
a
rapid
decrease
but
with
only
300%
of
the
amplitude
seen
in
(A)
followed
by
reassociation
as
before.
The
fluorescence
signal
has
the
same
amplitude
as
in
A.
The
length
of
the
steady
state
and
the
rate
of
the
reassociation
reaction
differ
in
A
and
B
because
of
the
different
ATPase
rates
in
the
two
experiments.
Reaction
conditions:
pH
7.0,
ionic
strength
0.012
M,
20
'C.
In
both
cases
the
solutions
were
mixed
at
the
small
arrow
(1)
200
ms
after
the
recorder
was
triggered.
From
[33]
with
permission.
equilibrium
proposal
of
the
3G
model
in
that
the
two
acto
*Sl
states
have
been
identified
and
the
ATP
causes
the
predominant
bound
state
to
switch
from
the
R
state
in
the
absence
of
nucleotide
to
the
A
state.
As
the
ATP
is
hydrolysed
and
the
products
are
sequentially
released
the
acto
SI
complex
pro-
gressively
reverts
to
the
rigor-like
low
fluorescence
A-M
or
A
-
M
N
state.
No
direct
information
is
available
on
the
acto
Sl
ADP
Pi
state,
as
addition
of
Pi
to
acto
*SI
-
ADP
results
in
minimal
binding
of
phosphate
to
the
complex
[17].
In
principle
the
acto
SI
ADP
-P
state
could
be
significantly
occupied
during
the
steady
state,
but
at
physiological
ionic
strength
the
affinity
of
actin
for
S1
ADP
P1
is
too
weak
for
actin
to
remain
bound.
At
low
ionic
strength
the
affinity
of
actin
for
Sl
nucleotide
complexes
is
greatly
increased,
but
the
rate
of
the
hydrolysis
step
Table
1.
Variation
in
the
value
of
K.
with
nucleotide
analogue
and
ionic
strength
Ionic
strength
(M)
Nucleotide
0.01
0.1
0.3
0.5
None
ADP
Pyrophosphate
ATP
ATPyS
ADP
+
vanadate
nd
>
20
2.3
280*
74t
40*
10
2.5
nd
10-2
All
values
from
[34],
except
*
from
[32]
and
t
from
[93]
becomes
sufficiently
slow
for
S1
ATP
to
be
a
major
component
of
the
steady
state
[36-38].
Kinetic
studies
The
pressure
perturbation
studies
in
the
absence
of
nucleotide,
described
above,
have
provided
kinetic
information
on
the
transition
between
the
two
attached
states
of
acto
SI
in
addition
to
the
equilibrium
measurements
[32].
Similar
studies
in
the
presence
of
nucleotide
in
combination
with
stopped
flow
measurements
have
defined
the
rate
of
the
transition
in
the
presence
of
ADP
and
ATP
[19,33,40].
A
summary
of
the
rate
and
equilibrium
constants
which
have
been
measured
for
steps
I
and
II
in
the
3G
model
is
provided
in
Table
2
and
they
are
discussed
below.
In
the
pressure-jump
experiment
in
the
absence
of
nucleotide
the
observed
rate
of
the
fast
relaxation
(attributed
to
k+i
+
k
II)
was
complete
in
the
pressure
release
time
(200
Its)
under
all
the
conditions
used.
This
limits
the
rate
of
the
transition
to
>
2000
s-i.
Thus
the
transition
between
the
two
attached
states
is
a
fast
equilibrium
process
in
the
absence
of
nucleotide.
It
is
also
fast
in
the
presence
of
ATP.
The
maximum
rate
of
the
ATP-induced
dissociation
of
rabbit
skeletal
acto
S1
is
too
fast
to
measure
at
ambient
temperatures
by
conventional
rapid
flow
methods.
It
has
been
measured
(120
s-1
[41])
for
arterial
myosin
and
estimated
as
1500
s-1
for
other
'slow'
myosins
[42].
The
rate
for
skeletal
myosin
can
however
be
measured
directly
at
temperatures
below
1
'C.
Millar
&
Geeves
[19]
were
able
to
measure
the
rate
over
the
range
-
15
to
0
'C
by
using
ethylene
glycol
solvents
to
prevent
freezing.
This
allowed
them
to
extrapolate
to
the
maximum
rate
at
20
°C
as
5000
s-I
and
this
was
assigned
to
a
protein
isomerization
which
preceded
dissociation
of
actin.
In
a
subsequent
study
ATPyS
was
used
in
place
of
ATP
[33]
as
it
has
been
shown
to
have
a
similar
affinity
for
S1
and
acto
*
S1
as
has
ATP
yet
the
maximum
rate
of
the
ATPyS-induced
dissociation
of
actin
was
one-tenth
of
that
of
ATP
[43].
This
allowed
the
isomerization
rate
to
be
measured
over
the
range
0-20
°C
and
demonstrated
the
validity
of
the
method
used
to
estimate
the
rate
of
the
reaction
for
ATP
from
studies
below
0
°C.
The
ATP-induced
dissociation
experiment
was
also
repeated
but
using
the
pyrene
signal
to
monitor
the
reaction.
This
demonstrated
that
the
event
monitored
by
pyrene
fluorescence
occurred
at
the
same
rate
as
the
isomerization
which
limited
the
rate
of
actin
dissociation
and
so
the
rate
of
A
M
T
-.A-M
T
was
assigned
to
5000
s-
.
The
significance
of
this
result
is
in
relation
to
the
requirement
of
both
the
3G
and
Eisenberg
models
for
a
reversal
of
the
weak-
to-strong
isomerization
before
detachment
of
the
crossbridge
takes
place.
The
rate
of
5000
s-1
in
solution
means
that
if
the
rate
of
reversal
of
the
A-to-R
transition
is
similar
in
an
unstrained
crossbridge
then
such
a
reversal
followed
by
detachment
can
occur
in
less
than
1
ms.
Thus,
even
if
the
isomerization
is
directly
Table
2.
Rate
and
equilibrium
constants
for
the
two-step
binding
of
actin
to
myosin-nucleotide
complexes
The
values
quoted
are
those
appropriate
for
pH
7,
20
°C,
ionic
strength
of
0.15 M.
The
experiments
to
define
the
constants
are
described
in
the
text.
Nucleo-
K,
k,1
k-I
k+11
k
-l
tide
(M-')
(M-1.
S-1) (S-1)
K11
(s-1)
(s-1)
None
5
x
104
ATP
103-104
ADP
5
x
104
2x
106
>
2x
106
4x
104
40
200
2000
>
500
102
50
2
10
4
10
5000
0.4
1991
6
Dynamics
of
muscle
contraction
coupled
to
force
generation,
the
lifetime
of
the
negatively
strained
crossbridge
will
not
be
significant.
In
marked
contrast
to
the
previous
two
rate
measurements
the
rate
of
the
isomerization
between
A-M
-D
and
A-
M
-D
has
been
measured
as
4
s-'.
ADP
binding
to
acto
SI
has
been
shown
to
be
a
rapid
equilibrium
reaction
with
Kr,
=
104
M-1,
and
a
dissociation
rate
constant
of
500
s-1
[25,44].
However,
the
change
in
pyrene
fluorescence
observed
on
adding
ADP
to
acto
SI,
under
conditions
where
no
dissociation
of
actin
takes
place,
was
4
s-1
[40].
This
allowed
the
assignment
of
the
rate
of
A-M
D
A
M
D
as
4
s-
.
This
rate
is
substantially
below
the
maximum
steady-state
actomyosin
ATPase
rate
in
solution
(and
the
ATPase
rate
of
a
rapidly
contracting
muscle
fibre)
and
therefore
little
flux
through
this
transition
will
take
place
during
rapid
turnover.
Furthermore
the
rate
of
ADP
dissociation
from
A-M
-D
has
been
estimated
to
be
2
s-1
([40];
see
later
discussion),
therefore
the
A-M
D
state
cannot
be
significantly
occupied
during
rapid
ATP
turnover.
This
contrasts
with
the
view
of
Sleep
&
Hutton
[17]
who
showed,
using
isotope
exchange
studies,
that
two
acto
Sl
ADP
states
existed
during
ATP
turnover,
only
one
of
which
could
be
readily
formed
by
incubating
ADP
with
acto
-SI
(A
*
M
D).
The
experimental
data
suggest
that
the
second
com-
plex
is
present
during
ATP
turnover
at
50
times
the
concentration
of
A-
M
*D
or
that
the
equilibrium
constant
is
50
in
favour
of
A-
M
D
or
a
combination
of
the
two.
Sleep
&
Hutton
went
on
to
discuss
the
possibility
that
A-
M
-
D
was
not
on
the
main
ATPase
pathway.
The
data
of
Geeves
[40]
and
Geeves
&
Jeffries
[34]
suggest
a
value
of
10
for
K2
but
at
the
low
ionic
strengths
used
by
Sleep
&
Hutton
this
becomes
>
20,
allowing
the
possibility
that
A-M
-
D
is
the
second
state
identified
by
Sleep
&
Hutton.
However
these
more
recent
data
suggest
that
at
high
turnover
rates
and
physiological
ionic
strength,
it
is
A-M
D
which
is
not
on
the
main
ATPase
pathway
as
the
dissociation
of
ADP
from
this
complex
or
its
isomerization
to
A
M
D
is
slower
than
the
turnover
rate.
This
need
not
be
the
case
when
the
turnover
rate
is
substantially
reduced,
such
as
occurs
in
a
muscle
which
is
prevented
from
shortening.
Under
these
isometric
conditions
the
ATPase
is
considerably
reduced
and
is
comparable
to
the
rate
of
the
transition
of
A-M
-
D
to
A-
M
-
D,
to
the
rate
of
loss
of
ADP
from
A-M
*
D
and
the
detachment
of
actin
from
A-M
D.
The
slow
rate
of
detachment
of
actin
from
this
complex
is
unusual
and
suggests
that
if
the
rate
is
similar
in
the
intact
muscle
then
this
complex
could
have
a
role
in
allowing
tension
to
be
maintained
without
rapid
hydrolysis
of
ATP;
i.e.
it
is
in
some
ways
comparable
to
the
catch
crossbridges
of
molluscan
muscle
[39,39a],
albeit
on
a
much
faster
time
scale.
[The
catch
state
of
molluscan
muscle
is
a
contraction
state
which
is
maintained
with
a
low
level
of
energy
expenditure
and
is
thought
to
operate
through
a
long-lived
force-holding
attached
crossbridge.
There
is
evidence
that
this
is
a
long-lived
actomyosin
-
ADP
state
[116]
and
if
this
is
correct
then
both
actin
and
ADP
must
detach
slowly
from
the
complex.
The
conversion
of
this
state
to
the
normal
actomyosin
-
ADP
state
with
a
fast
rate
of
ADP
dissociation
would
then
be
influenced
by
both
calcium
and
myosin
light
chain
phosphorylation.
Any
relationship
between
this
catch
actomyosin
*
ADP
state
and
the
A-M
-
D
state
has
not
been
investigated.
Although
the
properties
of
the
two
states
are
similar
their
lifetimes
must
differ
by
several
orders
of
magnitude.]
THE
IMPLICATIONS
OF
THE
TWO-STEP
BINDING
MODEL
The
detailed
solution
studies
discussed
so
far
lend
support
to
the
3G
model
of
actin
and
myosin
interactions
in
that
two-step
association
of
actin
with
myosin
and
myosin
nucleotide
complexes
have
been
identified
and
the
equilibrium
constant
of
the
isomerization
step
depends
upon
the
bound
nucleotide
in
the
manner
proposed.
I
want
now
to
turn
to
the
implications
and
predictions
of
this
model
for
force
generation
in
muscle.
The
most
widely
accepted
model
for
force
generation
in
muscle
is
the
cycling
crossbridge
model
(shown
in
its
simplest
form
in
Fig.
2).
In
this
model,
force
generation
is
the
result
of
a
cyclical
interaction
between
myosin
heads
and
actin
driven
by
ATP.
The
nature
of
the
structural
change
remains
undefined;
it
may
involve
only
the
actin-myosin
interface
such
that
the
two
proteins
roll
past
each
other,
a
gross
change
in
shape
or
size
of
a
single
myosin
head
or
it
could
involve
both
the
myosin
head
and
the
S2
fragment
as
in
the
model
of
Harrington
[45].
What
is
clear
is
that
the
structural
change
which
takes
place
has
to
be
sufficient
for
the
generation
of
the
mechanical
force
and
to
account
for
the
4-10
nm
axial
displacement
of
the
crossbridge
required
by
transient
mechanical
measurements
[46].
The
force-generating
(or
force-holding)
state
thus
created
has
to
have
a
lifetime
long
enough
to
account
for
the
level
of
force
produced
in
a
non-shortening
(isometric)
muscle
and
yet
have
a
lifetime
short
enough
to
allow
for
the
rapid
shortening
of
a
muscle
under
zero
load.
The
most
straight-
forward
possibility
is
that
the
lifetime
of
this
force-maintaining
state
is
dependent
upon
the
mechanical
condition
of
the
crossbridge,
i.e.
the
lifetime
of
the
force-holding
state
is
strain-
dependent;
the
higher
the
strain
the
longer
the
lifetime.
In
the
3G
model
the
structural
transition
(to
the
force-holding
state)
is
clearly
correlated
with
the
transition
from
the
associated
state
(A)
to
the
rigor-like
state
(R).
It
was
discussed
in
the
original
paper
how
this
transition
may
be
coupled
directly
or
indirectly
with
the
force-generating
event.
The
indirect
route
can
be
envisaged
as
the
structural
change
in
the
myosin
head
not
generating
force
itself
but
allowing
some
other
event
(such
as
S2
melting
in
Harrington's
model)
to
occur.
The
indirect
model
still
requires
some
coupling
of
the
state
of
the
myosin
head
with
the
state
of
the
force-generating
element,
and
in
the
absence
of
any
clear
evidence
for
how
this
coupling
might
occur
it
is
simpler
for
the
purposes
of
this
discussion
to
consider
the
direct
mechanism
alone;
i.e.
the
A-to-R
transition
is
the
force-generating
event
and
therefore
the
properties
ascribed
to
the
force-generating
event
above
must
apply
equally
to
the
A-to-R
transition.
This
transition
must
therefore
involve
a
structural
change
sufficient
to
account
for
the
mechanical
properties
of
the
crossbridge.
Two
other
conditions
can
be
identified
which
are
required
for
this
transition
to
be
the
force-generating
event.
First,
the
transition
must
be
coupled
to
the
release
of
products
of
the
ATPase
reaction,
i.e.
no
acceleration
of
the
release
of
products
can
occur
without
formation
of
the
R
state.
Secondly,
the
transition
in
the
organized
system
must
be
sensitive
to
mechanical
strain
and
parameters
which
affect
the
transition
must
also
affect
force
generation.
The
relationship
between
the
A-to-R
transition
and
these
three
conditions
will
be
considered
in
the
next
sections.
Structural
change
All
versions
of
the
cycling
crossbridge
model
of
contraction
require
at
least
two
structural
states
of
the
actomyosin
complex
with
the
transition
between
the
two
states
being
referred
to
as
the
'
power
stroke'
or
the
'force-generating
event'.
A
brief
review
of
the
possible
structural
changes
in
the
actomyosin
crossbridge
appeared
in
[47]
and
the
principal
structural
changes
discussed
are
shown
in
Fig.
6.
That
article
was
prompted
by
neutron-
scattering
data
that
suggest
that
any
deformation
of
the
myosin
head
shape
can
involve
no
more
than
20
%
of
the
mass
of
the
head
and
therefore
limits
the
form
of
any
structural
change
[48].
Structural
studies
of
myosin
and
actomyosin
have
so
far
been
limited
to
the
resolution
achieved
with
the
electron
microscope
and,
as
with
the
neutron-scattering
data,
no
evidence
of
a
gross
change
in
the
structure
of
the
myosin
head
has
been
obtained
Vol.
274
7
M.
A.
Geeves
(b)
(c)
(f)
Fig.
6.
Schematic
illustration
of
different
ways
of
producing
an
axial
shift
of
4-12
nm
of
the
rod
end
of
the
myosin
head
(M)
on
actin
(A)
during
the
contractile
cycle
of
muscle
The
black
helices
(T)
represent
tropomyosin
strands.
(a)
Swing
about
the
actin-myosin
interface;
(b)
roll
of
the
myosin
head
(roll
axis
indicated
by
R--R);
(c)
simple
axial
translation;
(d)
distributed
shear
along
the
myosin
head;
(e)
swing,
but
leaving
a
small
head
domain
(p)
unchanged;
(f)
privoting
one
major
domain
of
the
head
(D1)
relative
to
another
domain
(D2).
Squire
[47]
discussed
these
models
and
concluded
that
there
were
good
grounds
for
eliminating
models
(c),
(d)
and
(f),
leaving
models
(a)
and
(e)
as
possible
and
(b)
as
possible
but
unlikely.
Note
that
a
modified
form
of
(a)
could
involve
movement
of
a
rigid
myosin
head
firmly
attached
to
a
domain
of
the
actin
molecule
that
itself
moves
relative
to
the
rest
of
the
actin
filament.
From
[47]
with
permission.
Under
conditions
where
the
actin
is
strongly
attached
to
SI
and
the
R
state
predominates
then
the
two
residues
were
estimated
to
be
6
nm
apart.
Yet,
under
conditions
where
the
actin
is
weakly
attached
the
distance
is
reduced
to
<
3
nm,
suggesting
some
major
rearrangement
of
the
two
proteins.
These
distances
were
calculated
on
the
assumption
that
only
a
single
acto
-S1
complex
is
present
in
each
of
the
experiments.
If
more
than
one
complex
is
present
then
the
estimated
distance
represents
an
average
value.
It
would
be
of
interest
to
measure
the
distance
under
conditions
where
the
pyrene
signal
suggests
equal
occupancy
of
the
two
states.
The
kinetic
models
of
Fig.
3
do
not
give
any
direct
structural
information
on
the
nature
of
the
transition
between
the
two
actomyosin
states.
The
transition
could
represent
a
structural
change
in
the
myosin
head,
in
the
actin,
in
the
actomyosin
interface
or
a
combination
of
all
three
and
still
be
compatible
with
the
proposed
models.
However,
specific
kinetic
models
do
incorporate
a
relationship
between
the
nucleotide-binding
site
and
the
actin-binding
site
which
has
structural
implications.
For
example,
the
discussion
of
Goody
&
Holmes
[16]
on
the
reciprocal
nature
of
the
nucleotide
and
actin
binding
to
myosin
requires
communication
between
the
two
binding
sites.
The
kinetic
definition
of
actomyosin
*
nucleotide
states
does
provide
thermo-
dynamic
information
on
the
transition
between
states
which
can
set
limits
on
the
type
of
structural
change
involved.
Solution
studies
can
also
provide
information
on
the
feasibility
of
isolating
a
particular
state
for
detailed
structural
analysis.
One
problem
with
attempting
to
find
a
structure
of
actomyosin
other
than
the
stable
rigor
complex
is
that
such
states
may
be
very
short
lived.
Even
if
it
is
possible
to
define
conditions
where
the
weakly
bound
acto
Sl
ATP
is
the
predominant
species
in
solution
it
may
be
in
very
rapid
equilibrium
with
other
states
and
the
structural
analysis
could
sample
the
minority
species
disproportionately.
The
kinetic
studies
have
shown
that
when
nucleotide
binds
to
acto
SI
then
the
fluorescence
of
a
pyrene
group
covalently
attached
to
Cys-374
on
actin
senses
the
nucleotide
binding.
FRET
studies
have
shown
that
in
the
rigor
complex
Cys-374
of
actin
is
some
4
nm
away
from
the
nucleotide
binding
site
on
SI
[30].
Cys-374
is
therefore
unlikely
to
be
sensing
the
proximity
of
the
nucleotide
directly.
In
addition,
both
ADP
and
ATP
are
in
rapid
equilibrium
with
the
rigor-like
complex
at
a
rate
which
is
consistent
with
a
diffusion-limited
reaction
[19,25]
but
the
nucleotide-induced
change
in
pyrene
fluorescence
occurs
at
5000
s-1
for
ATP
and
4
s-'
for
ADP.
These
observations
suggest
that
the
pyrene
is
not
monitoring
the
nucleotide
binding
itself
but
a
nucleotide-induced
change
in
the
conformation
of
the
acto
*
SI
nucleotide
complex
which
is
communicated
from
the
nucleotide
binding
site
to
the
acto
*
SI
interface.
The
pyrene
is
therefore
not
monitoring
some
very
local
perturbation
affecting
only
its
own
environment.
[35,49].
Other
probes
of
the
structure
of
myosin
and
actomyosin,
fluorescence
energy
transfer
(FRET)
[30],
chemical
cross-linking
[50],
proteolytic
susceptibility
[51],
and
spectroscopic
probes
on
either
the
protein
or
nucleotide
[7,8,10,52,53,66]
have
revealed
changes
in
myosin
on
nucleotide
binding
and
in
the
acto
*SI
interface
between
rigor
and
weakly
attached
crossbridges.
These
approaches
can
be
sensitive
to
small,
local
changes
in
structure
and
are
therefore
not
inconsistent
with
the
absence
of
a
gross
structural
change.
Several
recent
reviews
have
discussed
the
detailed
structural
aspects
of
myosin,
actomyosin
and
the
crossbridge
[55,57,58].
One
approach
which
has
shown
evidence
of
a
substantial
conformational
change
in
acto
*
SI
is
the
use
of
FRET
to
measure
the
distance
between
Cys-374
on
actin
(the
same
site
as
labelled
by
pyrene)
and
Cys-177
on
the
alkali
1
light
chain
of
S1
[59,60].
Table
3.
Molar
volume
changes
for
reaction
of
biochemical
interest
Values
are
taken
from
[131].
Molar
volume
change
(cm3/mol)
Phosphate
ionization
(pK7)
Tris
ionization
Hydrogen
bond
formation
Myosin
filament
elongation
Microtubule
elongation
Chymotrypsin
denaturation
Myoglobin
denaturation
Acto
SI
isomerization
-24.0
+
1.0
+1.0
-280
-50
-43
-100
-80
to
-
100
1991
8
Dynamics
of
muscle
contraction
In
a
complementary
study
a
fluorescent
probe
on
the
ribose
of
ATP
[2'(3')-O-(N-methylanthraniloyl)-ATP,
abbreviated
to
mant-ATP]
has
been
used
to
probe
the
relationship
between
actin
and
nucleotide
binding
to
myosin
S1
[62].
These
studies
have
shown
that
the
binding
of
'mant'
nucleotides
to
S1
induces
a
2-3-fold
enhancement
of
mant
fluorescence,
but
the
mere
binding
of
nucleotide
to
acto
S1
does
not
induce
the
fluorescence
change.
The
fluorescence
change
monitors
a
conformational
change
in
the
complex
which
occurs
at
the
same
rate
and
to
the
same
extent
as
the
conformational
change monitored
by
the
pyrene
signal
on
actin.
As
the
same
transition
is
perturbing
the
environment
of
two
fluorescent
probes
which
are
4
nm
apart,
the
transition
is
not
the
result
of
a
small
local
rearrangement.
As
discussed
in
the
previous
section,
the
isomerization
of
acto
S5
can
be
perturbed
by
a
change
in
hydrostatic
pressure
both
in
the
absence
of
nucleotide
and
in
the
presence
of
ADP.
The
pressure-induced
change
in
the
equilibrium
constant
for
transition
(KII)
suggests
a
volume
change
of
80-120
cm3
mol-I
[32].
This
is
a
large
volume
change,
as
is
evident
from
comparison
with
the
volume
changes
listed
in
Table
3.
This
implies
that
the
conformational
change
results
in
a
structural
change
equivalent
to
the
exposure
to
the
solvent
of
either
four
buried
charged
groups,
four
buried
methyl
groups,
the
deprotonation
of
four
carboxyl
groups
or
a
combination
of
these
three.
The
volume
change
is
similar
to
that
observed
for
denaturation
of
small
proteins.
Thus,
the
fluorescence
signals
from
both
pyrene
and
mant
nucleotides
and
the
volume
changes
suggest
that
the
protein
isomerization
is
a
major
reorganization
of
the
structure
of
acto
*
SI
and
this
transition
can
take
place
in
the
presence
or
absence
of
nucleotide.
Changes
in
solvent
composition
can
result
in
the
destabilization
of
the
rigor-like
state
in
favour
of
the
attached
state.
Increases
in
ionic
strength
or
the
presence
of
organic
solvent
reduce
the
equilibrium
constant
of
the
transition
in
the
absence
of
nucleotide
or
in
the
presence
of
ADP
[32,34,63].
Table
1
documents
the
observed
values
of
KII
over
a
range
of
ionic
strengths
in
the
absence
of
nucleotide
and
in
the
presence
of
ADP.
Interestingly,
both
increases
in
ionic
strength
and
the
presence
of
organic
solvent
reduced
the
estimate
of
the
volume
change
of
the
reaction
[63].
Large
volume
changes
in
solution
normally
result
from
changes
in
hydration
shells
around
the
reacting
species.
Thus
the
presence
of
large
concentrations
of
either
ions
or
organic
molecules
could
produce
a
significant
amount
of
order
in
the
bulk
solvent,
reducing
the
free
energy
released
when
water
is
removed
from
the
hydration
shell
of
the
protein.
It
has
been
established
that
at
least
one
(and
probably
more
than
one)
conformational
change
takes
place
in
Sl
when
nucleotide
binds
even
in
the
absence
of
actin
[8,10,52,61,64,65].
Clearly
there
is
some
relationship
between
the
affinity
of
a
nucleotide
for
S1
and
the
ability
of
that
nucleotide
to
dissociate
actin
from
the
rigor
complex
(Table
4).
However,
the
relationship
between
the
conformational
changes
induced
in
SI
by
nucleotide
and
the
isomerization
of
the
acto
-S1
complex
discussed
here
is
Table
4.
Affinity
of
nucleotide
analogues
for
Si
and
acto
*S1
Affinity
of
Affinity
of
Affinity
of
N
for
M
N
for
A-M
A
for
M
N
(M-1)
(M-1)
(M-')
ATP*
1011
0.5x
103
ATPySt
107
1
x
103
AMP-PNPt
107
0.5
x
103
ADP§
106
5
x
103
References:
*[3,19],
t[33,52],
t[20],
§[401.
Vol.
274
<
10,
105
106
not
understood.
If
the
A-to-R
transition
is
a
change
in
the
conformation
of
S1
alone
then
studies
of
the
conformation
of
SI
and
SI
nucleotide
complexes
are
sufficient
to
define
the
molecular
changes
responsible
for
force
generation.
Indeed,
Shriver
&
Sykes
[7]
proposed
such
a
model
based
on
studies
of
SI
in
the
absence
of
actin.
Most
proteins
undergo
conformational
changes
when
a
ligand
binds
so
it
is
important
to
distinguish
between
small
local
changes
in
conformation
which
may
be
a
part
of
the
ligand
recognition/docking
process
and
a
major
conformation
change
in
which
information
is
transmitted
to
other
parts
of
the
molecule.
The
experimental
work
supporting
the
model
of
Shriver
[61]
and
Shriver
&
Sykes
[7]
suggested
that
both
temperature
and
nucleotides
can
be
used
to
manipulate
the
SI
conformation,
so
it
should
be
possible
to
test
how
the
different
conformations
interact
with
actin.
One
implication
in
the
original
Lymn
&
Taylor
model
was
that
the
conformational
change
that
takes place
in
the
myosin
head
during
the
power
stroke
is
reversed
when
actin
is
detached.
At
the
time,
the
only
significant
event
known
to
occur
during
the
detached
part
of
the
cycle
was
the
hydrolysis
step
and
so
it
was
reasonable
to
suggest
the
hydrolysis
step
as
the
reversal
of
the
conformational
change
which
results
in
the
power
stroke.
The
later
models
do
not
necessarily
attach
any
specific
significance
to
the
conformational
changes
occurring
when
actin
is
detached.
In
the
absence
of
direct
structural
evidence
we
have
only
indirect
information
to
guide
our
prejudices.
A
significant
observation
is
that the
transition
in
acto
Sl
occurs
with
a
significant
volume
change.
We
have
so
far
failed
to
find
any
evidence
of
a
significant
volume
change
on
either
ADP
or
AMP-PNP
binding
to
SI
in
the
absence
of
actin
(M.
A.
Geeves,
unpublished
work).
The
evidence
discussed
so
far
supports
the
view
that
a
major
conformational
change
takes
place
in
the
acto
-
Sl
complex
and
this
conformational
change
is
sensitive
to
the
nucleotide
bound
to
SI.
There
is
no
information
on
where
in
the
structure
this
change
takes
place
except
that
the
change
perturbs
the
en-
vironment
of
probes
attached
to
both
actin
and
nucleotide,
and
changes
the
distance
between
a
point
on
actin
and
a
point
on
the
myosin
light
chain.
The
values
of
KII
given
in
Table
1
define
the
fraction
of
an
actin-bound
S1
nucleotide
complex
in
the
two
states
A
and
R.
For
example,
addition
of
ADP
to
acto
Sl
in
0.3
M-KCI
will
result
in
30
%
of
the
complex
occupying
the
A
state.
Further
exploration
of
the
effect
of
solvent
conditions
on
KI,I
particularly the
nature
of
the
anion
used
and
the
presence
of
organic
solvent
[63],
may
be
able
to
increase
this
to
>
50
%.
The
ability
to
define
the
state
of
actin-bound
myosin
bound
may
be
useful
if
coupled
to
the
structural
methods
mentioned
earlier
(electron
microscopy,
FRET,
cross-linking
probes,
proteolysis
probes,
spectroscopic
probes
and
scattering
measurements).
The
relationship
between
the
isomerization
of
acto
*
S1
and
product
release
In
order
for
the
3G
model
to
account
for
the
steady-state
ATPase
behaviour
of
acto
*
S1
and
to
allow
the
coupling
of
the
ATPase
reaction
to
force
generation,
the
mere
binding
of
actin
to
a
myosin-product
complex
should
not
accelerate
the
release
of
products
from
SI.
Only
the
formation
of
the
R
state
(A
M
N)
should
accelerate
the
release
of
products.
This
was
implied
in
the
3G
model
by
stating
that
KI
was
independent
of
the
presence
of
nucleotide
on
S1
and,
for
this
to
be
true,
thermodynamic
balance
requires
that
the
binding
of
nucleotide
to
M
is
the
same
as
to
A-M.
The
thermodynamic
argument
only
applies
to
the
equi-
librium
constants,
not
to
the
rate
constants.
The
formation
of
the
A-M
state
could
increase
both
the
rate
of
binding
of
nucleotide
and
its
rate
of
release.
Little
direct
information
is
available
on
the
rate
of
product
dissociation
from
the
A-M
state,
as
this
state
is
difficult
to
isolate,
but
the
equilibrium
constants
which
have
been
9
M.
A.
Geeves
Attached
Low
force
\O
QOC
-IN
(a)
A
state
Low
force
(b)
Attached
High
force
#l
Detached
R
state
A-M-D-P
High
force
A-M-D
A-M
ATP
Detached
crossbridge
Fig.
7.
Relationship
between
the
'3G'
model
in
solution
and
the
mechanical
crossbridge
cycle
in
muscle.
(a)
The
simple
crossbridge
cycle
which
consists
of
three
mechanical
states.
The
detached
crossbridge
attaches
to
actin
rapidly
and
reversibly
to
form
the
'low
force'
crossbridge.
The
transition
from
the
low-force
to
the
high-force
state
is
shown
diagrammatically
as
a
change
in
the
angle
at
which
the
attached
crossbridge
binds
to
actin
and
which
occurs
with
the
stretching
of
an
elastic
element
shown
as
a
spring
in
the
S2
segment
of
the
crossbridge.
Binding
of
ATP
to
the
high-force
crossbridge
results
in
essentially
irreversible
detachment
of
the
crossbridge
from
actin.
(b)
The
'3G'
solution
model
is
redrawn
to
emphasize
the
correspondence
between
the
states
identified
in
solution
and
the
three
states
of
the
mechanical
cycle.
For
simplicity
only
those
states
which
are
thought
to
be
significantly
occupied
are
included.
The
detached
M
and
M-D
states
are
thought
to
be
rarely
occupied,
the
A-
M
T
state
is
transiently
occupied
each
time
ATP
binds
but
has
a
very
short
lifetime,
and
the
A-M
state
is
in
rapid
equilibrium
with
the
A-M
state
([A
M]/[A-M]
>
100).
measured
(see
above
and
Table
4)
are
consistent
with
little
change
in
affinity
of
nucleotide
for
M
and
A-M.
In
the
case
of
the
interaction
of
acto
*
SI
with
ADP,
all
of
the
rate
and
equilibrium
constants
have
been
estimated.
As
shown
in
Table
2,
KI
is
identical
in
the
presence
and
absence
of
ADP
and
therefore
the
affinity
of
ADP
for
M
and
A-M
must
be
the
same.
The
rate
of
ADP
dissociation
from
A-M
cannot
be
measured
directly,
but
in
a
complex
series
of
experiments
it
was
shown
that
ADP
dissociates
from
A-M
*
D
at
a
rate
which
is
not
significantly
faster
than
the
rate
at
which
it
dissociates
from
M
*
D
(2
s-I
[40]).
The
fluorescent
ADP
analogue
mant-ADP
can
be
displaced
from
its
complexes
with
S1
and
acto
-S
by
the
addition
of
a
large
excess
of
ATP.
The
observed
rates
of
mant-ADP
release
from
M,
A-M
and
A-
M
were
0.2,
0.5
and
400
s-
respectively
[62],
confirming
this
interpretation.
In
the
case
of
ATP
the
experiment
can
in
principle
be
done
by
displacing
isotopically
labelled
ATP
from
A-M
-T
at
very
low
ionic
strength.
The
experiment
has
been
performed
by
Barman,
Travers
and
their
colleagues
[65]
using
the
cold
chase
method.
The
interpretation
of
the
results
is
complicated
by
the
observation
that
the
SI
1
ATP
state
formed
immediately
on
release
of
actin
from
the
ternary
complex
is
not
the
same
as
that
formed
on
mixing
ATP
with
S1
[9,65].
The
cold
chase
experiments
do
however
show
that
the
ATP
bound
to
A-M
-
T
is
bound
tightly
with
a
dissociation
rate
constant
of
<
5
s-1.
The
myosin
product
complex
of
most
interest
is
the
complex
with
both
ADP
and
Pi
bound.
This
unfortunately
is
not
readily
formed
by
the
addition
of
Pi
to
acto-
S1
ADP
as
little
evidence
of
P1
binding
can
be
found.
Indeed,
calculations
suggest
a
binding
constant
of
>
1
M
for
P1
to
be
appropriate
[21].
In-
formation
on
the
binding
of
P1
comes
from
isotope
exchange
studies
during
hydrolysis
of
ATP.
Incubation
of
labelled
Pi
with
acto
SI
in
the
presence
of
unlabelled
ATP
can
lead
to
the
formation
of
labelled,
protein-bound
ATP
[17].
These
experiments
were
discussed
above
and
led
to
the
first
suggestion
of
two
acto
S1
ADP
complexes,
one
of
which
cannot
readily
be
formed
by
incubating
actin,
SI
and
ADP
together
but
which
can
bind
phosphate.
In
the
3G
model
this
state
could
be
A-M
D,
which
will
bind
Pi
with
an
affinity
similar
to
that
of
M
D.
We
have
made
some
preliminary
observations
which
suggest
that
Pi
can
bind
to
acto
Sl
ADP
at
high
pressure,
conditions
which
increase
the
concentration
of
A-M
-
D,
but
the
interpretation
of
these
experiments
is
complex
and
requires
confirmation
by
further
studies.
To
summarize,
the
data
available,
though
not
complete,
are
consistent
with
nucleotide
and
Pi
binding
to
A-M
with
an
affinity
similar
to
that
for
free
SI
and
with
the
fact
that
acceleration
of
the
release
of
products
of
the
ATPase
reaction
requires
the
formation
of
the
rigor-like
state.
The
relationship
between
the
isomerization
of
acto.Sl
and
force
generation
Studies
of
the
crossbridge
cycle
in
contracting
muscle
and
the
coupling
of
the
mechanical
events
to
the
biochemical
events
in
actomyosin
have
been
reviewed
several
times
recently
[76-78,117,118]
and
no
attempt
will
be
made
here
to
consider
all
of
this
evidence.
Only
those
experiments
which
bear
directly
on
the
interaction
between
actin
and
myosin
as
studied
in
solution
will
be
considered
in
detail.
At
its
simplest
level
the
mechanical
cycle
can
be
considered
as
a
three-step
cycle,
as
shown
in
Fig.
7(a).
Each
of
these
three
states
will
consist
of
a
subset
of
particular
myosin
or
actomysin
nucleotide
states.
There
is
general
agreement
that
the
detached
crossbridge
is
predominantly
a
mixture
of
M
*
ATP
and
M
ADP
*
P1
(i.e.
there
is
little
occupancy
of
the
M
and
M
*
D
states)
and
these
states
are
in
rapid
equilibrium
with
the
attached
low-force
state.
The
transition
from
the
low-
force
state
to
the
high-force
state
is
the
key
event,
the
details
of
which
have
not
been
resolved.
The
binding
of
ATP
to
the
high-
force
crossbridge
results
essentially
in
irreversible
detachment.
In
the
3G
model
there
is
an
obvious
correlation
between
the
three
principal
solution
states
and
the
three
states
of
the
mechanical
model.
This
assignment
implies
that
all
A-M
N
states
have
the
same
mechanical
properties.
This
may
be
true,
but
a
subtle
change
in
the
mechanical
properties
may
occur
as
the
nature
of
the
myosin-bound
nucleotide
changes.
The
available
energy
is
maximum
for
the
A-M
D
P
to
A
M
D
P
transition
when
coupled
with
the
loss
of
phosphate
which
traps
the
crossbridge
in
the
high-force
state.
The
3G
model
has
been
redrawn
in
Fig
7(b)
to
emphasize
the
correspondence
with
the
mechanical
model.
The
properties
of
the
A-to-R
state
transition
in
solution
have
been
described
above.
Significantly,
Coates
et
al.
[32]
pointed
out
that
this
transition
was
inhibited
by
increased
ionic
strength,
by
the
presence
of
ethylene
glycol
and
by
increases
in
hydrostatic
pressure.
The
data
in
Table
I
show
that
the
transition
is
sensitive
1991
lo
)
Dynamics
of
muscle
contraction
to
the
nucleotide
bound
to
myosin.
If
the
A-to-R
transition
occurs
id
the
contracting
fibre
and
is
coupled
to
the
force-
generating
event
(as
shown
in
Fig.
7),
then
these
same
treatments
would
be
expected
to
inhibit
force
generation.
There
is
evidence
to
support
this
in
most
cases.
Experiments
on
muscle
fibres
which
are
equivalent
to
those
which
can
be
readily
performed
in
solution
have
been
made
possible
by
the
development
of
the
use
of
skinned
muscle
fibres.
These
are
single
muscle
fibres
(or
small
bundles
of
such
fibres)
with
the
outer
membrane
chemically
[119]
or
mechanically
[120]
removed.
The
composition
of
the
solution
surrounding
the
crossbridges
can
therefore
be
readily
exchanged.
The
more
recent
development
of
photolabile
precursors
of
nucleotides
and
other
molecules
of
interest
(calcium,
inositol
trisphosphate)
has
allowed
kinetic
as
well
as
equilibrium
studies
to
be
made
on
such
fibres
[79-84].
Two
approaches
to
the
study
of
the
effect
of
nucleotide
or
other
factors
such
as
the
presence
of
ethylene
glycol,
on
the
mechanical
properties
of
the
crossbridge
have
been
made.
In
the
first,
nucleotide
is
added
to
a
muscle
fibre
in
a
mechanical
and
biochemical
equilibrium
state
such
as
rigor.
In
the
second,
the
muscle
fibre
is
perturbed
during
a
steady-state
contraction.
A
muscle
goes
into
rigor
in
the
absence
of
nucleotide
and
will
hold
a
fixed
tension
with
no
expenditure
of
energy.
The
addition
of
ethylene
glycol,
ADP
or
the
nucleotide
analogue
AMP-PNP
to
rigor
fibres
has
been
shown
to
induce
a
reversible
decline
in
the
measured
tension
(or
a
rightwards
shift
in
the
length-tension
relationship)
for
a
variety
of
muscle
types
[70,115,121].
In
complementary
experiments
the
extent
of
nucleotide
binding
to
the
crossbridges
increased
as
the
rigor
fibre
was
stretched
[115,127].
Marston
et
al.
[115]
suggested
that
these
effects
were
compatible
with
a
perturbation
of
the
equilibrium
between
the
low-
and
high-force
states
of
the
crossbridge,
nucleotide
or
ethylene
glycol
favouring
the
low-force
state.
In
a
complex
system
such
as
a
muscle
fibre
it
is
dangerous
to
extrapolate
too
readily
between
the
isolated
pure
proteins
in
solution
and
the
complex
mechanochemical
interactions
present
in
the
organized
system.
However,
while
these
effects
cannot
be
attributed
solely
to
the
influence
of
ADP,
AMP-PNP
and
ethylene
glycol
on
the
A-to-R
transition
in
fibres,
the
effects
are
in
the
expected
direction
and
are
of
the
order
of
magnitude
expected
from
solution
studies.
If
solution
studies
could
be
extrapolated
directly
to
single
muscle
fibres
then
a
10
MPa
pressure
rise
would
be
predicted
to
induce
a
small
(<
1
%)
decline
in
rigor
tension.
This
is
rather
small
to
be
detected
and
in
fact
the
observed
tension
changes
in
a
rigor
fibre
are
dominated
by
the
effects
of
pressure
on
the
length
of
an
elastic
element
in
series
with
the
crossbridge
[110].
Such
effects
on
the
elastic
element
can
also
be
seen
in
the
active
muscle,
but
in
this
case
the
effects
are
small
compared
to
the
effect
on
the
crossbridge
itself.
Studies
of
the
effect
of
pressure
on
these
elastic
elements
will
provide
information
on
the
structural
nature
of
the
elements;
however,
these
considerations
are
not
central
to
the
current
argument
and
will
not
be
discussed
here.
In
a
steady-state
contraction,
muscle
is
calcium-activated,
is
hydrolysing
ATP
and
is
generating
a
steady
active
tension.
If
the
crossbridges
are
independent
force-generating
elements
then
tension
is
directly
proportional
to
the
number
of
crossbridges
in
the
high-force
state.
A
perturbation
of
the
crossbridge
cycle
which
changes
the
fraction
of
crossbridges
in
the
high-force
state
will
therefore
change
the
measured
tension.
The
effects
of
ionic
strength,
hydrostatic
pressure
and
the
addition
of
ADP
or
P1
on
the
steady
active
tension
have
been
reported.
Several
studies
have
shown
that
the
level
of
isometric
tension
in
an
actively
contracting
muscle
fibre
is
sensitive
to
the
ionic
strength
of
the
bathing
solution
[68,69,1
1
1].
In
a
complementary
series
of
experiments
Gulati
&
Babu
[1
12]
demonstrated
that
the
effect
of
ionic
strength
could
not
be
attributed
to
changes
in
the
fibre
lattice
and
concluded,
therefore,
that
the
reduction
in
isometric
force
was
due
to
effects
on
the
crossbridge
cycle.
The
75
0
reduction
in
isometric
force
observed
in
frog
fibres
over
a
range
of
KCI
concentrations
from
0
to
0.2
M
has
both
the
direction
and
the
order
of
magnitude
expected
for
the
effect
of
KCI
on
K,
as
shown
in
Table
1.
However,
it
is
known
that
in
solution
ionic
strength
has
marked
effects
on
nucleotide
binding
to
both
myosin
and
actomyosin,
on
the
interaction
between
actin
and
myosin
in
the
presence
and
absence
of
nucleotide,
and
on
the
rate
of
the
ATP
hydrolysis
step.
Any
of
these
effects
could
lead
to
a
change
in
the
isometric
force
by
perturbing
one
or
more
steps
of
the
mechanical
cycle.
The
application
of
hydrostatic
pressure
to
an
isometrically
contracting
muscle
fibre
produced
a
reversible
depression
of
tension
of
0.8
%
per
MPa
pressure
rise
over
the
range
0.1-10
MPa.
(This
effect
has
since
been
observed
on
the
tetanic
tension
of
small
bundles
of
intact
electrically
stimulated
fibres
[71]
and
similar
results
were
originally
reported
on
whole
muscles
in
the
1930s
[73,74].)
Subsequent
studies
on
the
influence
of
ADP
and
Pi
on
the
observed
amplitude
of
the
pressure
effect
[75],
on
the
effect
of
pressure
on
the
equatorial
X-ray
scattering
[1
13]
and
on
the
time
scale
of
tension
recovery
following
a
rapid
release
of
high
pressure
[110]
support
the
contention
that
pressure
is
perturbing
a
crossbridge
event.
Once
again,
the
direction
and
size
of
the
pressure
effect
is
compatible
with
the
effect
of
pressure
on
the
A-to-R
transition
in
solution.
Evidence
for
two
states
of
the
actomyosin
nucleotide
complex
in
muscle
comes
from
studies
of
Pi
binding.
Isotope
exchange
studies
using
either
32P
or
180
have
shown
that
Pi
binds
to
an
actomyosin
ADP
complex
(and
is
incorporated
into
protein-
bound
ATP)
more
readily
in
a
skinned
muscle
fibre
during
an
isometric
contraction
than
in
a
rigor
or
relaxed
muscle
[67,122,128].
This
has
been
interpreted,
like
the
equivalent
experiments
with
purified
proteins
in
solution
[17],
as
demon-
strating
the
presence
of
an
additional
actomyosin
-
ADP
com-
plex
which
is
only
present
at
significant
concentrations
during
a
steady-state
contraction.
Addition
of
P1
to
a
contracting
isometric
muscle
results
in
a
reversible
depression
of
the
isometric
tension
by
up
to
500%
[123].
In
kinetic
studies
the
observed
rate
of
the
tension
decline
following
rapid
release
of
P1
from
caged
P1
is
faster
than
the
turnover
rate
of
the
ATPase
reaction
and
shows
evidence
of
saturation
at
high
Pi
concentrations
[125,126].
This
has
been
interpreted
in
terms
of
a
two-step
binding
reaction;
Pi
initially
binds
to
an
actomyosin
-
ADP
crossbridge
and
then
an
isomerization
of
the
complex
occurs
which
results
in
a
lower
isometric
force.
This
isomerization
could
correspond
to
a
reversal
of
the
A-M
D-Pi
to
A-M-D
Pi
transition
in
the
3G
model.
Preliminary
studies
of
the
rate
of
tension
recovery
in
single
skinned
muscle
fibres
following
a
rapid
release
of
10
MPa
pressure
show
that
the
rates
of
the
observed
tension
changes
have
similar
P1
dependence
to
those
seen
in
the
caged
P1
experiments.
Addition
of
millimolar
concentrations
of
ADP
to
an
iso-
metrically
contracting
muscle
increases
tension
by
up
to
300%
[123,124].
The
data
are
compatible
with
a
model
where
ADP
competes
with
ATP
for
the
force-holding
crossbridge
and
thereby
increases
the
lifetime
of
the
high-force
state
(i.e.
ADP
inhibits
step
3).
Pate
&
Cooke
[114]
have
modelled
such
a
system
in
detail
for
a
crossbridge
cycle
excluding
actomyosin
isomerization
steps.
The
introduction
of
such
steps
in
Fig.
7(b)
should
not
affect
that
interpretation
significantly.
The
influence
of
increased
hydrostatic
pressure
on
isometric
tension
is
less
in
the
presence
of
ADP
(6.5
%
per
10
MPa)
and
greater
in
the
presence
of
P1
(13
%)
than
in
control
measurements
Vol.
274
I
I
M.
A.
Geeves
(8.0
%).
This
result
can
be
understood
by
considering
the
effect
of
pressure
on
a
first
order
equilibrium
constant,
K
(or
the
ratio
between
two
complexes
in
a
steady
state).
The
relationship
between
pressure
change
(AP)
and
the
change
in
the
equilibrium
constant
(AK)
is
defined
by
AK
AV-AP
K
R-T
where
A
V
is
the
molar
volume
change
for
the
reaction
and
R
is
the
gas
constant.
If
K
=
[Y]/[X]
then
the
change
in
[Y]
is
maximal
when
K
=
1.
In
solution
the
volume
change
of
the
A-to-R
transition
is
100
cm3
mol-
1,
which
means
KII
decreases
by
a
factor
of
2
at
10
MPa.
If
the
8
0
drop
in
tension
were
due
solely
to
a
2-fold
reduction
in
ratio
of
high-force
to
low-force
crossbridges
(HF/LF),
then
it
can
be
shown
that
KII
in
the
fibre
is
10.5.
The
value
of
KII
would
be
13
in
the
presence
of
ADP
and
5.7
in
the
presence
of
Pi.
Thus
the
data
are
consistent
with
P.
decreasing
and
ADP
increasing
the
ratio
of
HF/LF
bridges
and
thereby
altering
the
pressure
sensitivity
of
the
A-to-R
transition.
These
calculations
are
meant
for
illustrative
purposes
rather
than
suggesting
that
these
are
the
real
values
in
the
muscle
fibre.
Many
control
experiments
need
to
be
performed
before
the
effects
of
pressure
can
be
solely
attributed
to
effects
on
KII
in
the
fibre.
The
experimental
data
quoted
above
do
not
amount
to
a
strong
case
to
support
the
model
of
Fig.
7.
What
they
do
show
is
that
there
is
evidence
of
two
mechanical
states
of
the
attached
crossbridge
which
are
in
a
steady-state
equilibrium.
Additionally,
there
is
some
evidence
that
treatments
which
reduce
KII
in
solution
also
perturb
the
equilibrium
between
the
two
attached
mechanical
states.
The
data,
although
in
most
cases
preliminary,
are
sufficient
for
the
model
to
be
given
serious
consideration
when
attempting
to
interpret
mechanical
and
biochemical
data
from
intact
muscle
fibres.
The
information
presented
here
does
not
address
directly
the
fundamental
question
of
how
the
biochemical
and
mechanical
events
are
coupled
in
the
crossbridge
nor
does
it
define
the
nature
of
the
structural
change
in
the
crossbridge.
However,
the
model
in
solution
and
its
extension
to
the
crossbridge
cycle
in
fibres
does
provide
a
framework
which
can
define
in
biochemical
terms
when
the
A-to-R
transition
takes
place.
This
information
can
be
used
in
conjunction
with
structural
and
mechanical
studies
to
define
the
relationship
between
the
structural,
mechanical
and
biochemical
state
of
the
crossbridge.
UNRESOLVED
PROBLEMS
AND
FUTURE
PROSPECTS
The
detailed
experimental
evidence
on
the
interaction
between
actin
and
SI
in
solution
discussed
in
this
review
is
consistent
with
the
3G
model
proposed
in
1984.
However,
it
is
clear
that
the
phosphate-release
step
remains
the
key
to
understanding
the
relationship
between
the
actomyosin
ATPase
and
the
force-generating
mechanism,
as
was
identified
some
15
years
ago
[3,23].
And
although
the
use
of
isotope
exchange
methods,
with
both
32P
and
180
[17,67],
have
provided
a
method
of
probing
this
step,
the
almost
irreversible
nature
of
this
event
in
solution
means
that
we
still
have
little
direct
information
on
the
relationship
between
phosphate
release
and
acto
SI
interaction.
These
steps
are
more
accessible
in
the
intact
muscle
fibre
where
the
coupling
of
the
ATPase
to
force
generation
results
in
a
higher
occupancy
of
the
states
involved
in
phosphate
release.
The
experimental
approach
to
the
actomyosin
ATPase
in
muscle
is
quite
different
and
beyond
the
scope
of
this
discussion.
However,
the
ability
of
a
solution
model
to
account
for
experimental
observations
in
the
intact
system
must
be
the
ultimate
test
of
the
model.
There
are
several
major
problems
in
extrapolating
from
any
study
of
purified
acto
-SI
in
solution
to
the
intact
muscle
fibre,
some
of
which
have
been
discussed
in
recent
reviews
of
studies
of
the
intact
system
[76-78].
The
principal
problems
are
how
the
three-dimensional
lattice
geometry
of
the
proteins
in
the
muscle
fibre
and
the
presence
of
mechanical
strain
affect
the
rate
and
equilibrium
constants
measured
in
solution.
These
questions
can
only
be
addressed
in
the
intact
system
and
increasingly
sophisticated
methods
are
being
applied
to
the
problem,
i.e.
photogeneration
of
nucleotides,
Ca2+
and
other
effectors
such
as
IP3
[79-84];
mechanical,
temperature
and
hydrostatic
pressure
perturbations
of
muscle
fibres
[71,75,85-89];
and
in
vitro
motility
assays
[90,91].
These
studies
have
shown
that
in
outline
the
events
of
the
ATPase
mechanism
remain
the
same
as
in
solution,
but
as
these
studies
progress
the
questions
asked
become
questions
of
detail,
not
of
overall
principle.
The
challenge
to
the
solution
biochemist
is
to
keep
pace
with
the
advances
made
in
understanding
the
intact
system.
For
many
years
SI
was
con-
sidered
an
adequate
model
of
the
myosin
ATPase
and
pure
actin
a
good
model
of
the
activated
thin
filament
(actin
-
troponin
tropomyosin
in
the
presence
of
calcium).
However,
when
modelling
the
co-operative
behaviour
of
the
intact
muscle,
small
differences
in
detail
can
make
major
changes
to
the
behaviour
of
the
system.
It
is
known
that
the
presence
of
tropomyosin
and
troponin
(Tm/Tn)
on
the
thin
filament
even
in
the
presence
of
calcium
produce
changes
in
the
affinity
of
actin
for
SI
and
SI
l
nucleotide
complexes
[92,93]
and
changes
in
the
maximum
ATPase
of
acto
S1
[94,95].
We
do
not
yet
know
at
which
steps
of
the
overall
mechanism
Tm/Tn
exert
their
effects.
There
is
evidence
that
Tm/Tn
influence
the
actin-binding
steps
both
in
the
presence
and
absence
of
calcium
[96,97]
and
the
effects
on
the
ATPase
could
be
a
result
of
modifying
the
P1
release
rate
or
the
A-to-R
transition
[98,99].
In
a
similar
way
there
is
little
evidence
to
suggest
that
there
is
any
co-operative
interaction
between
the
two
S1
heads
in
myosin
(or
HMM)
in
the
way
in
which
the
heads
interact
with
nucleotide.
However
few
experiments
have
addressed
the
question
of
inter-
action
between
the
heads
in
binding
to
actin.
The
theoretical
problem
of
comparing
the
affinity
of
two
SI
molecules
with
a
single
HMM
molecule
has
been
discussed
[100],
and
calculations
based
on
the
measured
affinities
of
SI
and
HMM
suggest
that
the
two
heads
of
HMM
bind
more
weakly
than
two
S1
heads
[16,101].
The
differences
in
behaviour
of
the
two
heads
may
not
be
significant
in
the
rigor
state
where
binding
is
very
tight,
but
in
the
presence
of
nucleotide
(where
KII
is
smaller)
these
effects
could
become
more
important.
Some
studies
of
actomyosin
interactions
in
muscle
in
the
presence
of
pyrophosphate
have
been
interpreted
in
terms
of
co-operative
binding
of
myosin
heads
to
actin
[102,103].
It
is
possible
that
when
both
heads
of
HMM
have
ATP
bound
and
only
weak
binding
to
actin
takes
place
(i.e.
the
A*
M
-
N
or
R
state
is
not
occupied)
then
only
one
head
of
HMM
is
likely,
statistically,
to
bind
to
actin
at
a
time,
but
once
one
head
binds
in
the
A
*
M
*N
state
the
probability
of
the
second
head
binding
is
greatly
enhanced;
i.e.
the
binding
is
co-operative
during
a
kinetic
cycle.
The
probability
of
two
heads
binding
simultaneously
will
depend
upon
the
lifetime
of
the
A
M
N
state
and
this
could
be
significantly
longer
in
an
isometrically
contracting
muscle
(low
ATPase
rate)
compared
to
a
shortening
muscle
(high
ATPase
rate).
Such
considerations
may
not
be
significant
in
solution,
but
in
studies
of
the
intact
system
such
co-operative
behaviour
of
the
two
heads
could
become
of
increasing
importance.
The
use
of
fluorescent
reporter
groups
on
proteins
and
on
nucleotides
should
make
these
problems
experimentally
ap-
proachable.
The
pyrene
label
on
actin
will
give
a
signal
for
each
myosin
head
which
forms
a
rigor-like
bond
irrespective
of
the
behaviour
of
the
second
head
[27,31]
and
the
same
should
be
true
1991
12
Dynamics
of
muscle
contraction
for
mant
nucleotides.
This
will
allow
the
degree
of
attached
and
rigor-like
binding
states
to
be
identified
for
HMM
in
the
presence
of
various
nucleotides
and
nucleotide
analogues.
Similarly,
the
mant
and
pyrene
signals
in
conjunction
with
fluorescent
probes
of
the
state
of
the
troponin-tropomyosin
complex
[104,105]
should be
able
to
delineate
the
relationship
between
the
acto
*
SI
isomerization
discussed
here,
the
nucleotide
dissociation
rate
and
the
state
of
the
actin
tropomyosin
co-operative
unit.
The
major
goal
of
understanding
the
generation
of
mechanical
force
in
terms
of
the
behaviour
of
the
individual
protein
components
remains
out
of
reach,
but
the
development
of
methods
which
can
be
used
in
the
muscle
fibre
as
well
as
on
the
isolated
proteins
will
bring
the
goal
much
closer.
The
use
of
photolabile
nucleotides
has
made
significant
contributions
in
the
last
5
years
and
will
continue
to
do
so.
The
use
of
perturbation
methods
in
solution
and
in
muscle
fibres
is
now
beginning
to
contribute.
Spectroscopic
probes
which
can
be
used
in
the
muscle
fibre
have
been
used
for
some
time,
but
problems
of
specificity
of
labelling
and
of
labels
modifying
protein
behaviour
have
limited
the
exploitation
of
this
approach.
However
the de-
velopment
of
a
new
generation
of
labels
such
as
the
mant
nucleotides
[106]
and
the
potential
of
exchanging
labelled
proteins
into
muscle
fibres
[107,108]
promise
to
remove
these
limitations.
These
developments
should
provide
the
framework
for
an
understanding
of
the
relationship
between
the
myosin
ATPase
and
force
development.
And
finally,
the
publication
of
the
atomic
structure
of
actin
[109a,109b],
and
the
successful
appli-
cation
of
molecular
genetic
methods
to
both
actin
[129]
and
myosin
fragments
[130]
bring
us
to
the
point
where
we
can
begin
to
ask
questions
about
the
mechanism
of
force
generation
at
the
atomic
level.
I
would
like
to
thank
H.
Gutfreund,
P.
Knight
and
N.
Millar
for
detailed
comments
on
this
manuscript.
The
author
is
a
Royal
Society
University
Research
Fellow
and
this
work
was
additionally
supported
by
The
Wellcome
Trust
and
the
European
Economic
Community.
REFERENCES
1.
Huxley,
A.
F.
(1980)
The
Sherrington
Lecture
XIV,
Liverpool
University
Press
2.
Huxley,
H.
E.
(1985)
J.
Exp.
Biol.
115,
17-30
3.
Trentham,
D.
R.,
Eccleston,
J.
F.
&
Bagshaw,
C.
R.
(1976)
Q.
Rev.
Biophys.
9,
217-281
4.
Taylor,
E.
W.
(1979)
CRC
Crit.
Rev.
Biochem.
6,
102-164
5.
Sleep,
J.
A.
&
Smith,
S.
J.
(1981)
Curr.
Top.
Bioeng,
11,
239-286
6.
Stein,
L.
A.,
Chock,
P.
B.
&
Eisenberg,
E.
(1981)
Proc.
Natl.
Acad.
Sci.
U.S.A.
78,
1344-1356
7.
Shriver,
J.
W.
&
Sykes,
B.
D.
(1981)
Biochemistry
20,
2004-2012
8.
Rosenfeld,
S. S.
&
Taylor,
E.
W.
(1984)
J.
Biol.
Chem.
259,
11920-11929
9.
Biosca,
J.
A.,
Barman,
T.
E.
&
Travers,
F.
(1984)
Biochemistry
23,
2428-2436
10.
Geeves,
M.
A.
&
Millar,
N.
C.
(1988)
Biochem.
J.
249,
735-749
11.
Lymn,
R.
W.
&
Taylor,
E.
W.
(1971)
Biochemistry
10,
4617-4623
12.
Stein,
L.
A.,
Schwartz,
R.
P.,
Chock,
P.
B.
&
Eisenberg,
E.
(1979)
Biochemistry
18,
3895-3909
13.
Greene,
L. E.
&
Eisenberg,
E.
(1980)
J.
Biol.
Chem.
255,
549-554
14.
Eisenberg,
E.
&
Greene,
L.
E.
(1980)
Annu.
Rev.
Physiol.
42,
293-309
15.
Eisenberg,
E.
&
Hill,
T.
L.
(1985)
Science
227,
999-1006
16.
Goody,
R.
S.
&
Holmes,
K.
C.
(1983)
Biochim.
Biophys.
Acta
762,
13-39
17.
Sleep,
J.
A.
&
Hutton,
R.
L.
(1980)
Biochemistry
19,
1276-1283
18.
Geeves,
M.
A.
&
Gutfreund,
H.
(1982)
FEBS
Lett.
140,
11-15
19.
Millar,
N.
C.
&
Geeves,
M.
A.
(1983)
FEBS
Lett.
160,
141-148
20.
Konrad,
M.
&
Goody,
R.
S.
(1982)
Eur.
J.
Biochem.
128,
547-555
21.
Geeves,
M.
A.,
Goody,
R.
S.
&
Gutfreund,
H.
(1984)
J.
Muscle
Res.
Cell.
Motil.
5,
351-361
22.
Finlayson,
B.,
Lymn,
R.
W.
&
Taylor,
E.
W.
(1969)
Biochemistry
8,
811-819
23.
White,
H.
D.
&
Taylor,
E.
W.
(1976)
Biochemistry
15,
5818-5826
24.
Marston,
S.
B.
(1982)
Biochem.
J.
203,
453-460
25.
Siemankowski,
R.
F.
&
White,
H. D.
(1984)
J.
Biol.
Chem.
259,
5045-5053
26.
Trybus,
K.
M.
&
Taylor,
E.
W.
(1980)
Proc.
Natl.
Acad.
Sci.
U.S.A.
77,
7209-7213
27.
Kouyama,
T.
&
Mihashi,
K.
(1981)
Eur.
J.
Biochem.
114,
33-38
28.
Trayer,
H.
R.
&
Trayer,
I.
P.
(1983)
Eur.
J.
Biochem.
135,
47-49
29.
Marston,
S.
B.
(1980)
J.
Muscle
Res.
Cell
Motil.
1,
305-320
30.
Botts,
J.,
Takashi,
R.,
Turgeson,
P.,
Hozumi,
T.,
Muhlrad,
A.,
Momet,
D.
&
Morales,
M.
(1984)
Proc.
Natl.
Acad.
Sci.
U.S.A.
81,
2060-2064
31.
Criddle,
A.
H.,
Geeves,
M.
A.
&
Jeffries,
T.
(1985)
Biochem.
J.
232,
343-349
32.
Coates,
J.
H.,
Criddle,
A.
H.
&
Geeves,
M.
A.
(1985)
Biochem.
J.
232,
351-356
33.
Geeves,
M.
A.,
Jeffries,
T.
E.
&
Millar,
N.
C.
(1986)
Biochemistry
25,
8454-8458
34.
Geeves,
M.
A.
&
Jeffries,
T.
E.
(1988)
Biochem.
J.
256,
41-46
35.
Walker,
M.
&
Trinick,
J.
(1980)
J.
Muscle
Res.
Cell
Motil
9,
359-366
36.
Johnson,
K.
A.
&
Taylor,
E.
W.
(1978)
Biochemistry
17,
3432-3442
37.
Chock,
S.
P.,
Chock,
P.
B.
&
Eisenberg,
E.
(1979)
J.
Biol.
Chem.
254,
3236-3243
38.
Geeves,
M.
A.
&
Trentham,
D.
R.
(1982)
Biochemistry
21,2782-2789
39.
Jewell,
B.
R.
(1959)
J.
Physiol.
(London)
149,
154-177
39a.
Cornelius,
F.
(1982)
J.
Gen.
Physiol.
70,
821-834
40.
Geeves,
M.
A.
(1989)
Biochemistry
28,
5864-5871
41.
Eccleston,
J.
F.,
Geeves,
M.
A.,
Trentham,
D.
R.,
Bagshaw,
C.
R.
&
Mwra,
U.
(1975)
The
Molecular
Basis
of
Motility
(Heilmeyer,
L.,
ed.),
pp.
42-52,
Springer-Verlag,
Berlin
42.
Marston,
S.
B.
&
Taylor,
E.
W.
(1980)
J.
Mol.
Biol.
139,
573-600
43.
Goody,
R.
S.
&
Hofmann,
W.
(1980)
J.
Muscle
Res.
Cell
Motil.
1,
101-115
44.
White,
W.
D.
(1977)
Biophys.
J.
17,
40a
45.
Harrington,
W.
F.
(1971)
Proc.
Natl.
Acad.
Sci.
U.S.A.
68,
685-689
46.
Ford,
L.
E.,
Huxley,
A.
F.
&
Simmons,
R.
M.
(1977)
J.
Physiol.
(London)
269,
441-515
47.
Squire,
J.
(1988)
Nature
(London)
335,
590-591
48.
Curmi,
P.
(1988)
J.
Mol.
Biol.
203,
781-798
49.
Walker,
M.,
Knight,
P.
&
Trinick,
J.
(1985)
J.
Mol.
Biol.
184,
535-542
50.
Mornet,
D.,
Bertrand,
R.,
Pantel,
P.,
Audemard,
E.
&
Kassab,
R.
(1981)
Nature
(London)
292,
301-306
51.
Mornet,
D.,
Bertrand,
R.,
Pantel,
P.,
Audemard,
E.
&
Kassab,
R.
(1981)
Biochemistry
20,
2110-2120
52.
Bagshaw,
C.
R.,
Eccleston,
J.
F.,
Eckstein,
F.,
Goody,
R.
S.,
Gutfreund,
H.
&
Trentham,
D.
R.
(1974)
Biochem.
J.
141,
351-364
53.
Eccleston,
J.
F.
&
Bayley,
P.
M.
(1980)
Biochemistry
19,
5050-5056
54.
Reference
deleted
55.
Vibert,
P.
&
Cohen,
C.
(1988)
J.
Muscle
Res.
Cell
Motil.
9,
296-305
56.
Offer,
G.
&
Knight,
P.
(1988)
Dev.
Meat
Sci.
4,
63-171
57.
Audemard,
E.,
Bertrand,
R.,
Bonet,
A.,
Chaussepied,
P.
&
Mornet,
D.
(1988)
J.
Muscle
Res.
Cell
Motil.
9,
197-218
58.
Thomas,
D.
D.
(1987)
Annu.
Rev.
Physiol.
49,
691-709
59.
Bhandari,
D.
G.,
Trayer,
H.
R.
&
Trayer,
I.
P.
(1985)
FEBS
Lett.
187,
160-166
60.
Trayer,
H.
R.
&
Trayer,
I.
P.
(1988)
Biochemistry
27,
5718-5727
61.
Shriver,
J.
W.
(1986)
Biochem.
Cell
Biol.
64,
265-276
62.
Woodward,
S.
K.
A.,
Eccleston,
J.
F.
&
Geeves,
M.
A.
(1991)
Biochemistry,
in
the
press
63.
Geeves,
M.
A.
&
Goldman,
W.
(1990)
Biochem.
Soc.
Trans.
18,
584-585
64.
Garland,
F.
&
Cheung,
H.
C.
(1979)
Biochemistry
18,
5281-5289
65.
Trybus,
K.
M.
&
Taylor
E.
W.
(1982)
Biochemistry
21,
1284-1294
66.
Goodearl,
A.
J.,
Levine,
B.
A.
&
Trayer,
I.
P.
(1985)
J.
Muscle
Res.
Cell
Motil.
6,
71
67.
Webb,
M.
R.
&
Trentham,
D.
R.
(1981)
J.
Biol.
Chem.
256,
10910-10916
68.
Brandt,
P.
W.,
Cox,
R.
N.,
Kwai,
M.
&
Robinson,
T.
(1982)
J.
Gen.
Physiol.
79,
997-1016
69.
Ashley,
C.
C.
&
Moisesca,
D.
G.
(1977)
J.
Physiol.
(London)
270,
627-652
70.
Clarke,
M.
L.,
Rodger,
C.
D.,
Tregear,
R.
T.,
Bordas,
J.
&
Koch,
M.
(1980)
J.
Muscle
Res.
Cell.
Motil.
1,
195-196
71.
Geeves,
M.
A.
&
Ranatunga,
K.
W.
(1987)
Proc.
R.
Soc.
London
Ser.
B
232,
217-226
72.
Geeves,
M.
A.
&
Ranatunga,
K.
W.
(1990)
J.
Physiol.
(London)
425,
16P
Vol.
274
13
M.
A.
Geeves
73.
Brown,
D.
E.
S.
(1934)
J.
Cell.
Comp.
Physiol.
4,
257-281
74.
Brown,
D.
E.
S.
(1936)
J.
Cell.
Comp.
Physiol.
8,
141-157
75.
Fortune,
N.
S.,
Geeves,
M.
A.
&
Ranatunga,
K.
W.
(1989)
J.
Muscle
Res.
Cell
Motil.
10,
113-123
76.
Hibberd,
M.
G.
&
Trentham,
D.
R.
(1986)
Annu.
Rev.
Biophys.
Chem.
15,
119-161
77.
Goldman,
Y.
E.
(1987)
Annu.
Rev.
Physiol.
49,
637-654
78.
Homsher,
E.
&
Millar,
N.
C.
(1990)
Annu.
Rev.
Physiol.
52,
875-896
79.
Kaplan,
J.
G.,
Forbush,
B.,
III
&
Hoffman,
J.
P.
(1978)
Biochemistry
17,
1929-1935
80.
Goldman,
Y.
E.,
Hibberd,
M.
G.
&
Trentham,
D.
R.
(1984)
J.
Physiol.
(London)
354,
577-604
81.
Hibberd,
M.
G.,
Dantzig,
J.
A.,
Trentham,
D.
R.
&
Goldman,
Y.
E.
(1985)
Science
228,
1317-1319
82.
Tsien,
R.
Y.
&
Zucker,
R.
S.
(1986)
Biophys.
J.
50,
843-853
83.
Kaplan,
J.
G.
&
Ellis-Davis,
G.
C.
R.
(1988)
Proc.
Natl.
Acad.
Sci.
U.S.A.
85,
6571-6575
84.
Walker,
J.
W.,
Somlyo,
A.
V.,
Goldman,
Y.
E.,
Somlyo,
A.
P.
&
Trentham,
D.
R.
(1987)
Nature
(London)
327,
249-252
85.
Ford,
L.
E.,
Huxley,
A.
F.
&
Simmons,
R.
M.
(1977)
J.
Physiol.
(London)
269,
441-515
86.
Kwai,
M.
&
Halverson,
H.
R.
(1989)
Biophys.
J.
55,
595-603
87.
Goldman,
Y.
E.,
McCray,
J.
A.
&
Ranatunga,
K.
W.
(1987)
J.
Physiol.
(London)
392,
71-95
88.
Davis,
J.
S.
&
Harrington,
W.
F.
(1987)
Proc.
Natl.
Acad.
Sci.
U.S.A.
84,
975-980
89.
Bershitsky,
S.
Y.
&
Tsaturyan,
A.
K.
(1989)
Biophys.
J.
56,
809-816
90.
Harada,
Y.,
Naguchi,
A.,
Kishino,
A.
&
Yanagida,
T.
(1987)
Nature
(London)
326,
805-808
91.
Kron,
S.
J.
&
Spudich,
J.
A.
(1986)
Proc.
Natl.
Acad.
Sci.
U.S.A.
83,
6272-6276
92.
Greene,
L.
E.
&
Eisenberg,
E.
(1980)
Proc.
Natl.
Acad.
Sci.
U.S.A.
77,
2616-2620
93.
Geeves,
M.
A.
&
Halsall,
D.
J.
(1986)
Proc.
R.
Soc.
London
Ser.
B.
229,
85-95
94.
Lehrer,
S.
S.
&
Morris,
E.
P.
(1982)
J.
Biol.
Chem.
257,
8073-8080
95.
Murray,
J.
M.,
Knox,
M.
K.,
Trueblood,
C.
E.
&
Weber,
A.
(1982)
Biochemistry
21,
906-915
96.
Greene,
L.
E.
(1982)
J.
Biol.
Chem.
260,
1279-1285
97.
Trybus,
K.
M.
&
Taylor,
E.
W.
(1980)
Proc.
Natl.
Acad.
Sci.
U.S.A.
77,
7209-7213
98.
Chalovich,
J.
M.,
Chock,
P.
B.
&
Eisenberg,
E.
(1981)
J.
Biol.
Chem.
256,
575-578
99.
Geeves,
M.
A.
&
Halsall,
D.
J.
(1987)
Biophys.
J.
52,
215-220
100.
Hill,
T.
L.
&
Eisenberg,
E.
(1980)
Biophys.
Chem.
11,
271-281
101.
Greene,
L.
E.
(1981)
Biochemistry
20,
2120-2126
102.
Pate,
E.
&
Cooke,
R.
(1986)
Biophys.
J.
49,
265a
103.
Anderson,
M.
L.
&
Schoenberg,
M.
(1987)
Biophys.
J.
52,
1077-1082
104.
Rosenfeld,
S.
S.
&
Taylor,
E.
W.
(1985)
J.
Biol.
Chem.
260,
252-261
105.
Lehrer,
S.
S.
&
Ishii,
Y.
(1988)
Biochemistry
27,
5899
106.
Hiratsuka,
T.
(1983)
Biochim.
Biophys.
Acta
742,
496-508
107.
Zot,
H.
G.,
Guth,
K.
&
Potter,
J.
D.
(1986)
J.
Biol.
Chem.
261,
15883-15890
108.
Simmons,
R.
M.
&
Szent-Gyorgyi,
A.
G.
(1985)
J.
Physiol.
(London)
358,
47-64
109a.
Kabsch,
W.,
Mannherz,
H.
G.,
Suck,
D.,
Pai,
E. F.
&
Holmes,
K.
C.
(1990)
Nature
(London)
347,
37-44
109b.
Holmes,
K.
C.,
Popp,
D.,
Gebhard,
W.
&
Kabsch,
W.
(1990)
Nature
(London)
347,
44
49
110.
Ranatunga,
K.
W.,
Fortune,
N.
S.
&
Geeves,
M.
A.
(1990)
Biophys.
J.
58,
1-10
111.
Gulati,
J.
&
Podolsky,
R.
J.
(1981)
J.
Gen.
Physiol.
78,
233-257
112.
Gulati,
J.
&
Babu,
A.
(1982)
Science
215,
1109-1112
113.
Knight,
P.,
Fortune,
N.
&
Geeves,
M.
(1990)
J.
Muscle
Res.
Cell
Motil.
11,
73
114.
Pate,
E.
&
Cooke,
R.
(1989)
J.
Muscle
Res.
Cell
Motil.
10,
181-196
115.
Marston,
S.
B.,
Tregear,
R.
T.,
Roger,
C.
D.
&
Clarke,
M.
L.
(1979)
J.
Mol.
Biol.
128,
111-126
116.
Takahashi,
M.
&
Morita,
F.
(1989)
J.
Biochem.
(Tokyo)
106,
868-871
117.
Cooke,
R.
(1986)
CRC
Crit.
Rev.
Biochem.
21,
53-118
118.
Brenner,
B.
(1987)
Annu.
Rev.
Physiol.
49,
655-672
119.
Szent-Gyorgi,
A.
G.
(1949)
Biol.
Bull.
96,
140-161
120.
Natori,
R.
(1954)
Jikeikai
Med.
J.
1,
119-126
121.
Tanner,
J.
W.,
Vallette,
D.
P.,
Thomas,
D.
D.
&
Goldman,
Y.
E.
(1989)
Biophys.
J.
55,
9a
122.
Webb,
M.
R.,
Hibberd,
M.
G.,
Goldman,
Y.
E.
&
Trentham,
D.
R.
(1986)
J.
Biol.
Chem.
261,
15557-15564
123.
Cooke,
R.
&
Pate,
E.
(1985)
Biophys.
J.
48,
789-798
124.
Lacktis,
J.
W.,
&
Homsher,
E.
(1987)
Biophys.
J.
51,
475a
125.
Dantzig,
J.
A.,
Lacktis,
J.
W.,
Homsher,
E.
&
Goldman,
Y.
E.
(1987)
Biophys.
J.
51,
3a
126.
Homsher,
E.
&
Millar,
N.
C.
(1989)
J.
Physiol.
(London)
419,
65p
127.
Khun,
H.
J.
(1977)
in
Insect
Flight
Muscle
(Tregear,
R.
T.,
ed.),
pp.
307-316,
North
Holland,
Amsterdam
128.
Ulbrich,
M.
&
Ruegg,
J.
C.
(1976)
Pfluger
Arch.
363,
219-222
129.
Drummond,
D.
R.,
Hennessey,
E.
S.,
Sparrow,
J.
C.
&
White,
D.
C.
S.
(1990)
Biophys.
J.
57,
327a
130.
Lozanne,
A.
&
Spudich,
J.
A.
(1987)
Science
236,
1086-1091
131.
Davis,
J.
S.
&
Gutfreund,
H.
(1976)
FEBS
Lett.
72,
199-207
1991
14